Neonates, especially premature neonates, requiring intensive care support constitute a highly vulnerable population at extreme risk for nosocomial or health care–associated infections. It has been estimated that as many as 6% to 22% of infants who survive 48 or more hours in a high-risk nursery or neonatal intensive care unit (NICU) acquire a nosocomial infection.1, 2 Although nosocomial infections have long been recognized in NICUs, only recently have data on rates been documented in the literature. As technology and treatments have advanced to significantly diminish mortality and morbidity among critically ill neonates, especially infants of very low birth weight (less than 1500g), this vulnerability has only increased, as a result of both more profound immune system immaturity and more frequent use of invasive interventions that bypass skin and mucous membrane barriers.1
Nosocomial infections in neonates carry high attendant morbidity and mortality and health care costs. Prevention and control of these infections, although highly desirable, present a formidable challenge to health care professionals. Because control over birth weight—the most significant predictor of nosocomial infection risk—is limited, proper NICU customs, environment, and procedures (e.g., hand hygiene, antimicrobial usage, catheter-related practices, skin and cord care, visitation policies, unit design, and staffing) can reduce the risk for infection in the NICU. Understanding the epidemiology of nosocomial infections in neonates and methods for their prevention and control is critical to minimizing poor outcomes. This chapter describes the epidemiology, etiology, and clinical characteristics of neonatal nosocomial infections as well as the methods required for effective infection prevention and control.
SPECIAL ISSUES FOR NEONATES
It is well recognized that the immune system of the newborn infant, especially the premature infant, is functionally inferior to that of older infants, children, and adults (see Chapter 4). The lineages of the cells that will develop into the immune system are present at the beginning of the second trimester. The major components of the neonatal immune system, including T cells, neutrophils, monocytes, and the complement pathways, are functionally impaired, however, when compared with those in older infants and adults. For example, neonatal neutrophils show decreased chemotaxis, diminished adherence to the endothelium, and impaired phagocytosis3, 4; neonatal complement levels and opsonic capacity also are reduced, particularly in the premature neonate.4, 5 In addition, neonatal T cell lymphokine production, cytotoxicity, delayed-type hypersensitivity, and help for B cell differentiation all are inferior when measured against those in adults.6 Antigenic naiveté may account for many of these differences; however, inherent immaturity also appears to account for certain inequities. For example, neonatal T cells are delayed in their ability to generate antigen-specific memory function after HSV infection, even in comparison with naive adult T cells.7
Passively acquired maternal immunoglobulin G (IgG) is the sole source of neonatal IgG. Soon after birth, maternal IgG levels begin to fall; weeks later, production of immunoglobulins by the neonate commences. Neonatal IgG levels reach about 60% of adult levels by 1 year of age.6 Unfortunately, because much of the maternal IgG is not transferred to the infant until the last 8 to10 weeks’ gestation, premature infants start with significantly lower levels of serum IgG than in their term counterparts, which persist throughout most of the first months of life.
Other issues specific to the premature neonate also affect the functional immune system. For instance, the immature gastrointestinal tract (lack of acidity worsened by use of histamine H2 blockers and continuous feedings) and easily damaged skin constitute open potential portals of entry for pathogens or commensals. In addition, like other intensive care unit populations, the NICU population frequently experiences extrinsic breeches of the immune system through use of intravascular catheters as well as other invasive equipment and procedures used to care for critically ill patients.
It is generally accepted that colonization with “normal flora” prevents, to some degree, colonization by pathogenic organisms. The neonate begins life essentially sterile. In the healthy term neonate, colonization occurs within the first few days of life. The organisms involved by site are α-hemolytic streptococci in the upper respiratory tract, Staphylococcus epidermidis and other coagulase-negative staphylococci (CoNS) on the skin, and gram-negative bacilli and anaerobes in the gastrointestinal tract. This process of colonization with normal flora is disrupted in infants cared for in an NICU in part because of exposure to the NICU environment, the hands of health care workers (HCWs), antimicrobial agents, and invasive procedures. As a result, the microflora of infants in the NICU can be markedly different from that of healthy term infants.8, 9 Multiple antimicrobial agent–resistant CoNS, Klebsiella, Enterobacter, and Citrobacter species colonize the skin and the respiratory and gastrointestinal tracts of a high proportion of NICU neonates by the second week of hospitalization.10, 11, 12, 13 In addition, neonates in the NICU become colonized not only with Candida albicans but also with non-albicans Candida species and Malassezia.14, 15, 16, 17
Because colonization of the neonate with pathogenic organisms is a prelude to invasive infection from the same pathogens,9 measures to prevent such colonization need to be considered. First, as a result of abnormal colonization, infants in the NICU themselves serve as an important reservoir of potential pathogens. Second, contamination of the hands of HCWs during routine patient care has been well documented.18 Thus, careful attention to hand hygiene before and after contact with patients and their environment, as well as decontamination of potential fomites, are crucial measures in preventing spread of colonization and infection.
EPIDEMIOLOGY
Incidence
Nosocomial infections in healthy term infants are uncommon unless other conditions require that they be cared for in the NICU for several days to weeks. On the other hand, these other conditions are frequent in neonates of very low birth weight (less than 1500g), who require prolonged NICU care. Understanding the epidemiology of nosocomial infections in NICUs can be challenging, because reported rates vary dramatically by institution. This variation probably results from use of nonstandard definitions of nosocomial infection and from differences in patient populations, such as mean gestational age, birth weight, and severity of underlying illness, which significantly affect the incidence of nosocomial infection.19
The National Nosocomial Infections Surveillance (NNIS) system is a national surveillance system of the Centers for Disease Control and Prevention (CDC) that uses standardized surveillance protocols and the involvement of multiple medical centers to provide benchmark data for the epidemiology of nosocomial NICU infections. Using standardized definitions, NNIS reported in 1996 that 13,179 nosocomial infections occurred between 1986 and 1994 in 10,296 neonates in 99 NICUs.20 In this study, rates of intravascular catheter– associated bloodstream infection, the most frequent nosocomial infection, ranged from fewer than 5 infections per 1000 umbilical or central catheter days in infants with a birth weight greater than 1500g to almost 15 infections per 1000 catheter days in the lowest-birth-weight group (less than 1000g).
Another national, multicenter surveillance study, the Pediatric Prevention Network’s (PPN) Point Prevalence Survey, was undertaken in 1999 to determine the point prevalence of nosocomial infections in NICUs and to define risk factors associated with development of these infections.21 This study included 827 infants from 29 NICUs. Of the 827 infants, 94 (11.4%) had an active nosocomial infection on the day of the survey. Bacteremia accounted for 53% of infections; lower respiratory tract infections, ear-nose-throat infections, and urinary tract infections accounted for 13%, 9%, and 9%, respectively (Table 35–1).
Table 35-1.
Distribution of NICU-Acquired Infections by Birth Weight and Site
| Birth Weight (g) |
No. of Patients |
No. of Infections |
||||||
|---|---|---|---|---|---|---|---|---|
| Total Surveyed | With Infections (%) | Total | Bacteremia (%) | Respiratory Infections (%) | ENT Infections (%) | UTIs (%) | Other Infections | |
| <500 | 13 | 1/13 (7.7) | 1 | 1/1 (100) | 0 | 0 | 0 | 0 |
| 501–1000 | 246 | 43/246 (17.5) | 58 | 31/58 (53.4) | 9/58 (15.5) | 5/58 (8.6) | 4/58 (7.0) | 9/58 (15.5) |
| 1001–1500 | 147 | 21/147 (14.3) | 26 | 15/26 (57.7) | 2/26 (7.7) | 2/26 (7.7) | 1/26 (3.8) | 6/26 (23.1) |
| 1501–2000 | 74 | 2/74 (2.7) | 2 | 2/2 (100) | 0 | 0 | 0 | 0 |
| 2001–2500 | 74 | 5/74 (6.8) | 5 | 2/5 (40) | 1/5 (20) | 1/5 (20) | 1/5 (20) | 0 |
| >2500 | 239 | 16/239 (6.7) | 17 | 7/17 (41.2) | 2/17 (11.8) | 2/17 (11.8) | 3/17 (17.6) | 3/17 (17.6) |
| Unknown | 34 | 6/347 (1.7) | 7 | 3/7 (42.8) | 1/7 (14.3) | 0 | 1/7 (14.3) | 2/7 (28.6) |
| Total | 827 | 94/827 (11.4) | 116 | 61/116 (52.6) | 15/116 (12.9) | 10/116 (8.6) | 10/116 (8.6) | 20/116 (17.2) |
| ENT, ear, nose, or throat; NICU, neonatal intensive care unit; UTIs, urinary tract infections. | ||||||||
Data from Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 139:821–827, 2001.
In contrast with the NICU setting, the frequency of nosocomial infection in well-baby nurseries has been estimated to be between 0.3% and 1.7%.22, 23, 24 In general, non–life-threatening infections such as conjunctivitis account for a majority of infections in the well-baby population. The remainder of this chapter focuses almost entirely on nosocomial infections in and control measures for the NICU setting.
Maternally Acquired Infections
For purposes of surveillance and tracking, all infections occurring in hospitalized newborns could be considered nosocomial. Infections that are manifested in the first few days of life, however, usually are caused by pathogens transmitted vertically from the maternal genital tract. Unfortunately, no precise time point perfectly distinguishes maternally acquired neonatal infections from those transmitted within the NICU. NNIS has attempted to address this issue by stratifying infections according to whether they are likely to be maternally acquired.20 In 89% of neonates who had an infection thought to be maternally acquired, onset occurred within 48 hours of birth. Use of a cutoff period of 48 hours or less to designate maternally acquired infections allowed 15.3% of bacteremias and 14.5% of pneumonias to be considered as originating from a maternal source. Maternally acquired bloodstream infections were more likely to be caused by group B streptococci, other streptococci, and Escherichia coli, whereas those not maternally acquired usually were caused by coagulase-negative staphylococci.20
Nonmaternal Routes of Transmission
In general, nonmaternal routes of transmission of microorganisms to neonates are divided into three categories: contact (from either direct or indirect contact from an infected person or a contaminated source), droplet (from large respiratory droplets that fall out of the air at a maximum distance of 3 feet), and airborne (from droplet nuclei, which can remain suspended in air for long periods and as a result travel longer distances). Specific microorganisms can be spread by more than one mechanism; in most instances, however, a single mode of spread predominates. The CDC has developed a system of precautions for the control of nosocomial infections that is based on these modes of transmission.25
Contact transmission of bacteria, viruses, and fungi on the hands of HCWs is arguably the most important yet seemingly preventable means of transmission of nosocomial infection. Spread of infection by this means can occur either by transmission of the HCW’s own colonizing or infecting pathogens or, more often, by transmission of pathogens from one patient to another. That the hands of HCWs become contaminated even in touching intact skin of patients has been well demonstrated.18 Poor compliance with hand hygiene is another means by which the hands of HCWs can spread organisms from one patient to another.26, 27 Furthermore, hands of HCWs have been implicated in multiple outbreaks with a variety of different organisms; through experimental studies, a causal link between hand hygiene and nosocomial infection has been established.28
Contact transmission by means of fomites also can occur and has been described as a potential mechanism of spread of pathogens in multiple NICU outbreaks. As described later in this chapter, implicated items have included linens, medical devices, soap dispensers, and breast pumps, to name a few. These observations highlight the need for careful attention to disinfecting items shared between infants.
Spread through large respiratory droplets is an important mode of transmission for pertussis and infections due to Neisseria meningitidis, group A streptococci, and certain respiratory viruses, whereas airborne transmission by means of droplet nuclei is relevant for measles, varicella, and pulmonary tuberculosis. For large droplet or droplet nuclei transmission, usually an ill adult, either an HCW or a parent, is the source of infection in an NICU setting. In general, these organisms are rare sources of outbreaks.
Infusates, medications, and feeding powders or solutions can be intrinsically or extrinsically contaminated and have been reported as the source of outbreaks due to a variety of different pathogens. It is important when possible to mix infusates in a controlled environment (usually the pharmacy), to avoid multiuse sources of medication, and to use bottled or sterilized feeding solutions when breast milk is not available.
Of course, nosocomial infection also can arise from endogenous sources within the neonate. The “abnormal flora” of the neonate residing in the NICU, however, is determined at least in part by the NICU environment and HCWs’ hands. With use of molecular techniques, even organisms typically considered to originate solely from normal flora (e.g., CoNS) have been shown to have clonal spread in the hospital setting, suggesting transmission by means of the hands of HCWs.29, 30
Risk Factors for Nosocomial Infection
As discussed earlier, infants in NICUs have intrinsic factors predisposing them to infection, such as an immature immune system and compromised skin or mucous membrane barriers. In addition, multiple extrinsic factors play important roles in the development of infection, such as presence of indwelling catheters, performance of invasive procedures, and administration of certain medications, such as steroids and antimicrobial agents.
Birth weight is one of the strongest predictors of risk for nosocomial infection. For instance, NNIS data demonstrate that compared with larger infants, low-birth-weight infants are at higher risk of developing bloodstream infections and ventilator-associated pneumonia, even after correction for central intravascular catheter and ventilator use.20 Similarly, in the PPN’s Point Prevalence Survey, infants weighing 1500g or less at birth were 2.69 (95% confidence interval [CI] 1.75% to 4.14%; P < .001) times more likely to have an infection than those weighing more than 1500g.21 The relationship between birth weight and nosocomial infection is complicated by multiple other factors that accompany low birth weight and also increase risk for nosocomial infection. Low birth weight, however, has been shown to be an independent predictor for nosocomial infection, after adjustment for use of vascular catheters, parenteral alimentation, and mechanical ventilation.31 It is likely that birth weight also is a surrogate marker for other unmeasured factors, such as immune system immaturity.
Central venous catheters (CVCs) increase the risk for development of nosocomial bloodstream infections. In a study by Chien and colleagues 19,507 infants admitted to 17 NICUs in Canada, nosocomial bloodstream infections were found to occur at a rate of 3.1 to 7.2 infections per 1000 catheter days, depending on the type of catheter, versus 2.9 infections per 1000 noncatheter days. Other studies have demonstrated that the association between CVCs and bloodstream infection is independent of birth weight.21 Mechanisms for CVC-related nosocomial bloodstream infections probably involve colonization of the catheter by means of the catheter hub, colonization of the skin at the insertion site,33 or hematogenous spread of pathogens from distant sites of infection or colonization. Bloodstream infections also can result from contaminated intravenous fluids, which have the potential for intrinsic or, especially with use of multiuse vials, extrinsic contamination.
Factors related to the management of CVCs influence the risk of infection. Disconnection of the CVC and the frequency of blood sampling through the catheter increase the frequency of catheter-related infections.34 By contrast, administration of a solution with heparin and exit-site antisepsis decreased infection. Lower frequency of CVC tubing changes (every 72 hours versus every 24 hours) was associated with increased catheter contamination, suggesting a potential for increased risk of infection.35 CVC management techniques, including use of antiseptic-impregnated dressings, antimicrobial-coated catheters, and avoidance of scheduled replacement of CVCs, are discussed in the most recent CDC recommendations, summarized in “Guidelines for the Prevention of Intravascular Catheter–Related Infection,” published in 2002 and prepared by the Hospital Infection Control Practice Advisory Committee.36
It has been suggested that use of peripherally inserted central catheters (PICCs) may be associated with a lower rate of infection than for other CVCs. Studies based in NICUs have yielded conflicting results. In a study by Chien and colleagues,32 the relative risk of bloodstream infection, after adjustment for differences in infant characteristics and admission illness severity, was 2.5 per 1000 catheter days for umbilical venous catheters, 4.6 for PICCs, and 4.3 for Broviac catheters, compared with no catheter (P < .05). Another study also documented similar rates of infection for Broviac catheters and for PICCs.37 By contrast, a higher rate of infection with Broviac catheters than with PICCs was suggested by Brodie and co-workers.38 Further study of different CVCs in NICU infants is needed to delineate infection risks for individual catheter types.
Parenteral alimentation and intralipids have been shown to increase risk of bloodstream infection in premature infants even after adjustment for other covariables such as birth weight and CVC use.38 Etiologic agents often associated are CoNS, Candida species, and Malassezia species. The pathogenesis of this association remains unclear. Potential hypotheses are many. Intralipids, for example, could have a direct effect on the immune system, perhaps through inhibition of interleukin-2.39 Alternatively, as with any intravenous fluids, parenteral alimentation has the potential for intrinsic and extrinsic contamination, and intralipids especially may serve as a growth medium for certain bacteria and fungi. Finally, total parenteral alimentation and intralipids delay the normal development of gastrointestinal mucosa because of lack of enteral feeding, encouraging translocation of pathogens across the gastrointestinal mucosa.
It is well accepted that mechanical ventilation is an important risk factor for nosocomial lower respiratory tract infection. A large multicenter study of 8263 neonates found that mechanical ventilation was a risk factor for bloodstream infection as well, even after adjustment for a number of covariables such as birth weight, parenteral nutrition, and umbilical catheterization.40 Clinically obvious respiratory infection appeared to precede some but not all cases of bloodstream infection associated with mechanical ventilation. The study authors suggested that the increased risk of mechanical ventilation could be attributed to colonization of humidified air, as well as to physical trauma from the endotracheal tube and its suctioning.
A number of medications critical to the survival of infants in the NICU increase risk of infection. Broad-spectrum antimicrobial agents, especially with prolonged use, are important in the development of colonization with pathogenic microorganisms.9 The widespread use of broad-spectrum antimicrobial agents has been associated with increased colonization with resistant organisms in many settings, including NICUs.19 In addition to colonization, antimicrobial agents also have been shown to increase risk of infection with resistant bacteria41 and with fungal pathogens.42 Other medications also appear to play a role in nosocomial infection. For instance, infants who receive corticosteroids after delivery are at approximately 1.3 to 1.6 times higher risk for nosocomial bacteremia in the subsequent 2 to 6 weeks than that observed for infants who do not receive this intervention.43, 44 In addition, colonization and infection with bacterial and fungal pathogens have been shown to increase with the use of H2 blockers.14, 31
Measures of illness severity have been developed, in part, in an effort to account for variations in birth weight–adjusted mortality scores between NICUs. The Score for Neonatal Acute Physiology (SNAP) was developed and validated by Richardson and associates,45 and the Clinical Risk Index for Babies (CRIB) was developed by the International Neonatal Network.46 These scores are highly predictive of neonatal mortality even within narrow birth weight strata and are predictive of nosocomial infection. Thus, in investigating potential risk factors for nosocomial infection, it is important to consider adjusting for illness severity using such measures, in addition to adjusting for other potential confounders.
Other risk factors related to infection include poor hand hygiene and environmental issues, such as understaffing and overcrowding.47, 48 These and related issues are discussed later in this chapter under “Prevention and Control.”
CLINICAL MANIFESTATIONS
Nosocomial infections can affect any body site or organ system and manifest in a multitude of different ways. NNIS and PPN data demonstrated that bloodstream infections are the most common manifestation of nosocomial infection and account for 32% to 53% of infections (Table 35–2; see also Table 35–1).20, 21 Respiratory infections and eye, ear, nose, or throat infections are second and third in frequency, whereas gastrointestinal infections, urinary tract infections, surgical site infections, meningitis, cellulitis, omphalitis, septic arthritis, and osteomyelitis are reported less frequently.20, 21
Table 35-2.
Most Common Pathogens Causing Nosocomial Infection in NICU Patients: Distribution by Site
| Pathogen | Bloodstream |
No. of Infections (%) |
Pneumonia | Surgical Site | |
|---|---|---|---|---|---|
| EENT | GI | ||||
| Coagulase-negative staphylococci (CoNS) | 3833 (51.0) | 787 (29.3) | 102 (9.6) | 434 (16.5) | 119 (19.2) |
| Staphylococcus aureus | 561 (7.5) | 413 (15.4) | 440 (16.7) | 138 (22.3) | |
| Group B streptococci | 597 (7.9) | 150 (5.7) | |||
| Enterococcus | 467 (6.2) | 92 (3.4) | 120 (4.6) | 55 (8.9) | |
| Candida species | 518 (6.9) | ||||
| Escherichia coli | 326 (4.3) | 163 (6.1) | 147 (13.9) | 152 (5.8) | 74 (12.0) |
| Other streptococcal species | 205 (2.7) | 199 (7.4) | 86 (3.3) | ||
| Enterobacter species | 219 (2.9) | 120 (4.5) | 58 (5.5) | 215 (8.2) | 47 (7.6) |
| Klebsiella pneumoniae | 188 (2.5) | 76 (2.8) | 104 (9.8) | 152 (5.8) | 39 (6.3) |
| Pseudomonas aeruginosa | 178 (6.6) | 308 (11.7) | |||
| Haemophilus influenzae | 72 (2.7) | 38 (1.4) | |||
| Viruses | 136 (5.1) | 317 (30.0a) | |||
| Gram-positive anaerobes | 99 (9.4) | ||||
| Other enteric bacilli | 8 (0.8) | ||||
| Miscellaneous organisms | 607 (8.1) | 449 (26.7) | 223 (21.0) | 570 (21.7) | 147 (23.7) |
| Total | 7521 (100) | 2685 (100) | 1058 (100) | 2665 (100) | 619 (100) |
| EENT, eye, ear, nose, or throat; GI, gastrointestinal; NICU, neonatal intensive care unit. | |||||
Rotavirus constitutes 96.4% of viruses isolated from gastrointestinal infections.
Data from Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance system. Pediatrics 98:357–361, 1996.
Bloodstream infections are the most common and one of the most potentially serious nosocomial infections that occur in NICU patients. Factors discussed earlier, including birth weight, intravascular catheters, mechanical ventilation, use of parenteral alimentation, and steroids, all have been shown to be associated with an increased risk of bloodstream infection. The most common pathogen associated with nosocomial bloodstream infections is CoNS (see Table 35–2). Staphylococcus aureus, Enterococcus, Candida species, E. coli, Enterobacter species, Klebsiella pneumoniae, and Pseudomonas aeruginosa also play important roles and are associated with higher morbidity and mortality rates than those associated with CoNS.49, 50 In one study, the frequency of fulminant sepsis (fatal within 48 hours) was estimated to be 56% (95% CI 38% to 72%) when the bloodstream infection was caused by Pseudomonas species, whereas it was only 1% (95% CI 0% to 4%) when infection was caused by CoNS.50 The difficulty of assigning an etiologic role to CoNS on the basis of one blood culture that could be contaminated probably accounts for some distortion of the incidence and mortality data related to this organism, and this problem is discussed in detail in Chapter 6.
Pneumonia accounts for 12% to 18% of NICU nosocomial infections20 and has been associated with prolonged hospital stay and increased mortality.51 Organisms most commonly associated with nosocomial pneumonia include CoNS, S. aureus, and P. aeruginosa (see Table 35–2). Mechanical ventilation and birth weight are important risk factors for nosocomial respiratory infections.51 Diagnosis of nosocomial respiratory infections requires correlation of microbiologic results with clinical findings and can be challenging in low-birth-weight infants because of the mostly nonspecific associated signs of illness and often misleading results of radiologic studies.52
Eye, ear, nose, and throat infections account for approximately 8% to 21% of infections, depending on birth weight.20 Common etiologic organisms include CoNS and S. aureus, although gram-negative organisms, such as E. coli, P. aeruginosa, and K. pneumoniae, also can be isolated from these sites (see Table 35–2). Conjunctivitis appears to be the most common of these infections, accounting for 54% to 76%, depending on birth weight.20 Risk factors for neonatal conjunctivitis identified in a study from Nigeria included vaginal delivery, asphyxia, and prolonged rupture of membranes.53
In the NNIS review, gastrointestinal infections were estimated to account for 5% to 11% of nosocomial infections, depending on birth weight. Necrotizing enterocolitis (NEC) was the most common presentation.20 NEC carries high morbidity and mortality rates. A review of 17 NEC epidemics estimated that surgery was required for a mean of 16% (range, 0% to 67%) of infants, and death occurred in a mean of 6% (range, 0% to 88%).54 In controlled studies, identified risk factors for NEC have included young chronologic age, low gestational age, low birth weight, and young age at first feeding.54 Implication of specific pathogens is complex, requiring careful selection of an appropriate control population and attention to how and where specimens are collected. Pathogens associated with NEC outbreaks have included Pseudomonas species, Salmonella species, E. coli, K. pneumoniae, Enterobacter cloacae, S. epidermidis, Clostridium species, coronavirus, and rotavirus.54, 55 The importance of infection control methods such as strict attention to hand hygiene and cohorting patients in the NICU is suggested by the observation that their implementation has been followed by resolution of the outbreak.55
ETIOLOGIC AGENTS
A detailed discussion of the cause of nosocomial sepsis and meningitis is found in the chapter on bacterial sepsis (Chapter 6) and chapters describing specific etiologic agents.
Gram-Positive Bacteria
S. aureus is a colonizing agent in neonates and has been a cause of nosocomial infection and outbreaks in well-baby nurseries and NICUs. Methicillin-resistant S. aureus (MRSA) has become a serious nosocomial pathogen, and outbreaks have been reported in many areas of hospitals, including nurseries.56, 57, 58 In addition to the usual manifestations of neonatal nosocomial infection (conjunctivitis, bloodstream infections, and pneumonia), nosocomial S. aureus infections can manifest as skin infections,59 bone and joint infections,60 parotitis,61 staphylococcal scalded skin syndrome,62, 63 toxic shock syndrome,56 and disseminated sepsis.
The role of the hands of HCWs in transmitting and spreading pathogenic organisms among infants was demonstrated with S. aureus in the 1960s.64, 65 Currently, in a majority of instances, S. aureus transmission is thought to occur by direct contact. Thus, it is not surprising that understaffing and overcrowding have been associated with S. aureus outbreaks in NICUs.57, 66 The potential for airborne transmission, however, has been suggested by the occurrence of “cloud babies,” described by Eichenwald and colleagues67 in 1960. “Cloud” HCWs also have been described; in such cases, the point source of an outbreak was determined to be a colonized HCW with a viral respiratory infection.59, 68 In one of these studies, dispersion of S. aureus from the implicated HCW was found to be much higher after experimental infection with rhinovirus.68 More recently, molecular techniques not only have defined outbreaks57 but also have demonstrated that transmission to infants probably occurs from colonized HCWs,62 and sometimes from colonized parents.69
Nasal mupirocin ointment has been used to control outbreaks of both methicillin-susceptible S. aureus and MRSA.62, 70 The pharynx, rather than the anterior nares, however, may be a more common site of colonization in neonates and infants,71 and eradication of the causative organisms with nasal mupirocin may be more difficult in this site.72
Coagulase-Negative Staphylococci
Since the early 1980s, CoNS has been the most common cause of nosocomial infection in the NICU.48 Recent NNIS and PPN surveillance estimate that 32% of total pathogens and 48% to 51% of bloodstream infections are caused by these organisms.20, 21 A 10-year, prospective, multicenter Australian study corroborated the fact that CoNS accounted for most infections and demonstrated that 57% of all late-onset infections during the study period were due to these organisms.73 This study and a U.S. study of 302 very low birth weight infants from two NICUs reported that the highest risk for CoNS infection was in the most premature infants.73, 74 In one study, infection usually manifested between 7 and 14 days of life and was accompanied by a mortality rate of 0.3%.73 Although associated with relatively low mortality rates, bacteremia due to CoNS has been correlated, by means of multivariate analysis, with prolonged NICU stay and increased hospital charges, even after adjustment for birth weight and severity of illness on admission.74
Many experts consider infection due to CoNS to be inevitable in neonates in the NICU. Molecular techniques suggest that infections due to S. epidermidis can result from clonal dissemination.29, 30 In one study, four clones accounted for 43 of 81 study strains (53%).29 This finding suggests that a portion of CoNS infections may be preventable by strict adherence to infection control practices. The fact that a hand hygiene campaign was associated with increased hand hygiene compliance and a lower rate of CoNS-positive cultures supports this contention.75
Enterococcus has been shown to account for 10% of total nosocomial infections in neonates, 6% to 15% of bloodstream infections, 0% to 5% of cases of pneumonia, 17% of urinary tract infections, and 9% of surgical site infections.20, 21 Sepsis and meningitis are common manifestations of enterococcal infection during NICU outbreaks75, 76; however, polymicrobial bacteremia and NEC frequently accompany enterococcal sepsis.77 Identified risk factors for enterococcal sepsis, after adjustment for birth weight, include use of a nonumbilical CVC, prolonged presence of a CVC, and bowel resection.77 Because Enterococcus colonizes the gastrointestinal tract and can survive for long periods of time on inanimate surfaces, the patient’s environment may become contaminated and, along with the infant, serve as a reservoir for ongoing spread of the organism.
The emergence of vancomycin-resistant enterococci (VRE) is a concern in all hospital settings, and VRE have been the cause of at least one outbreak in the NICU setting.78 In the neonate, resistant strains appear to cause clinical syndromes indistinguishable from those due to susceptible enterococci.77 The conditions promoting VRE infection, such as severe underlying disease and use of broad-spectrum antimicrobial agents, especially vancomycin, can be difficult to alter in many NICU settings. Guidelines for the prevention and control of VRE infection have been published; these focus on infection control tools such as rapid identification of a VRE-colonized or VRE-infected patient, cohorting, isolation, and barrier precautions.80
Historically, before the recognized importance of hand hygiene and the availability of antimicrobial agents, group A streptococci (GAS) were a major cause of puerperal sepsis and fatal neonatal sepsis. Although less common now, GAS continue to be a cause of well-baby and NICU outbreaks.81, 82, 83, 84 GAS-associated clinical manifestations include severe sepsis and soft tissue infections. One report described a high frequency of “indolent omphalitis”; in this outbreak, the umbilical stump appeared to be an important site of GAS colonization and an ongoing reservoir of the organism.81 Routine cord care included daily alcohol application. After multiple attempts, the outbreak finally was interrupted after a 15-day interval during which bacitracin ointment was applied to the umbilical stump in all infants, and affected infants received intramuscular penicillin. Molecular techniques have enhanced the ability to define outbreaks, and use of these techniques has suggested that transmission can occur between mother and infant, between HCW and infant, and between infants— probably indirectly on the hands of HCWs.82, 83 In one recurring outbreak, inadequate laundry practices appeared to be a contributing factor.85
NNIS data have shown that group B streptococci (GBS) infections account for less than 2% of non–maternally acquired nosocomial bloodstream and pneumonia infections.20 A number of studies from the 1970s and 1980s demonstrated nosocomial colonization of infants born to GBS-negative women.86, 87, 88, 89, 90 These studies suggested a rate of transmission to babies born to seronegative mothers as high as 12% to 27%.87, 88 A recent case-control study evaluating risk factors for late-onset GBS infection demonstrated that premature birth was a strong predictor.91 In that study, 50% of the infants with late-onset GBS infection were born at less than 37 weeks of gestation (compared with 15% of controls), and only 38% of the mothers of these infants were colonized with GBS, suggesting possible nosocomial transmission of GBS during the NICU stay.
The hands of HCWs are assumed to account for the transmission of most cases of nosocomial GBS infection. Breast milk also has been implicated as a potential mode of acquisition, however. In one report, GBS probably was transmitted from breast milk to one set of premature triplets between days 12 and 63 of life.92 Two maternal vaginal swabs taken before delivery did not grow GBS, but repeated cultures of the mother’s breast milk yielded a pure growth of GBS (greater than 105 colony-forming units [CFU]/mL) despite no evidence of mastitis. In this report, antimicrobial therapy administered to the mother appeared to eradicate the organism.
Gram-Negative Bacteria
The Enterobacteriaciae family has long been recognized as an important cause of nosocomial infection. Neonatal infection can be manifested as sepsis, pneumonia, urinary tract infections, and soft tissue infections; morbidity and mortality rates frequently are high.93 Enterobacter species, K. pneumoniae, E. coli, and Serratia marcescens are the members of the family Enterobacteriaciae most commonly encountered in the NICU.
Enterobacter species have been estimated to account for 3% of bloodstream infections, 8% of cases of pneumonia, and 8% of surgical site infections in the NICU setting (see Table 35–2). Outbreaks due to Enterobacter species in NICUs have been associated with thermometers,94 a multidose vial of dextrose,95 intravenous fluids,96 and powdered formula,97 as well as with understaffing, overcrowding, and poor hand hygiene practices.98 In one outbreak in which contaminated saline was linked to the initial cases, subsequent ongoing transmission was documented, presumably by means of the hands of HCWs and the environment.99 In that study, early gestational age, low birth weight, exposure to personnel with contaminated hands, and E. cloacae colonization of the stool were associated with E. cloacae bacteremia, whereas use of CVCs and mechanical ventilation was not.
K. pneumoniae has been estimated to account for a similar proportion of infections in the NICU setting to that identified for Enterobacter species. Investigations in outbreaks involving Klebsiella species have implicated contaminated breast milk,100 infusion therapy practices,101 intravenous dextrose,102 cockroaches, 134 disinfectant,104 incubator humidifiers,105 thermometers, oxygen saturation probes,106 and ultrasonography coupling gel.108 In a surveillance study of 383 NICU infants in Brazil, 50% became colonized with Klebsiella.13 In this study, colonization was associated with use of a cephalosporin and aminoglycoside combination therapy, as well as with longer duration of the NICU stay.
E. coli has been estimated to cause 4% of bloodstream, 14% of gastrointestinal, and 12% of surgical site infections. E. coli also has been responsible for outbreaks of pyelonephritis,108 gastroenteritis,109, 110 and NEC.
S. marcescens is an opportunistic pathogen that survives in relatively harsh environments. Disease due to S. marcescens often is manifested as meningitis, bacteremia, and pneumonia.111 S. marcescens infections have a high potential for morbidity and mortality.112, 113 S. marcescens outbreaks have been associated with, but not limited to, contaminated soap,114 multiuse bottles of theophylline,115 formula,115 enteral feeding additives,116 breast pumps,117, 118 and transducers from internal monitors.116 Although point source environmental contamination is important in Serratia outbreaks, in many of these outbreaks and in reports in which no point source was identified,119 patient-to-patient spread of the organism by means of the hands of HCWs appeared to be an important mechanism of spread.113
Extended-spectrum β-lactamases (ESBLs) are plasmid-mediated resistance factors produced by members of the Enterobacteriaceae family. ESBLs inactivate third-generation cephalosporins and aztreonam. They most commonly occur in K. pneumoniae and E. coli but have increasingly been found in other gram-negative bacilli. Colonization with ESBL-producing organisms has been associated with administration of certain antimicrobials and longer duration of hospitalization, whereas infection has been associated with prior colonization and use of CVCs.13 That the ESBL-containing plasmids can be transmitted to other Enterobacteriaceae organisms has been demonstrated in NICU outbreaks in which the implicated plasmid spread from Klebsiella species to E. coli, E. cloacae, and Citrobacter freundii.120, 121 The gastrointestinal tract in neonates and the hands of HCWs serve as reservoirs for members of the Enterobacteriaceae family. Thus, in general, measures aimed at controlling spread of organisms in this family have focused on attention on hand hygiene, cohorting of patient and staff, and observation of isolation precautions.121, 122
P. aeruginosa, an opportunistic pathogen that persists in relatively harsh environments, frequently has been associated with nosocomial infections and outbreaks in the NICU setting. Nosocomial P. aeruginosa infections vary in their clinical presentation, but the most common manifestations are respiratory, ear, nose, or throat and bloodstream infections.21 From the PPN data it has been estimated that P. aeruginosa species account for 6.8% of total pathogens, 5% of bloodstream infections, and 15% of respiratory infections.21 P. aeruginosa infections, particularly bloodstream infections, have been associated with a very high mortality rate.123
Feeding intolerance, prolonged parenteral alimentation, and long-term intravenous antimicrobial therapy have been identified as risk factors for Pseudomonas infection.123 Outbreaks due to P. aeruginosa have been linked with contaminated hand lotion,124 respiratory therapy solution, 125 a water bath used to thaw fresh-frozen plasma,126 a blood gas analyzer,127 and bathing sources. In one case, neonatal Pseudomonas sepsis and meningitis were shown by pulsed-field gel electrophoresis to be associated with shower tubing from a tub used by the infant’s mother during labor.128 Of importance, HCWs and their contaminated hands also have been linked with Pseudomonas infections in the NICU setting. In a study of a New York outbreak, recovery of Pseudomonas from the hands of HCWs was associated with older age and history of use of artificial nails.129 This and other studies suggest that the risk of transmission of Pseudomonas to patients is higher among HCWs with onychmycosis or those who wear long artificial or long natural nails.129, 130 As a result of these and other findings, the CDC revised its 2002 hand hygiene recommendations to include a recommendation against the presence of HCWs with artificial fingernails in intensive care units.131
Bordetella pertussis is a rare cause of nosocomial infection in neonates. When B. pertussis infection occurs, parents and HCWs typically are the source. A parent was the source of an outbreak involving three neonates and one nurse in a special care nursery in Australia.132 In 1999 in Knoxville, Tennessee, an outbreak involving six neonates probably was due to transmission of infection by an HCW.133 As a result of the Tennessee outbreak, 166 infants received erythromycin prophylaxis. Subsequently, an increase in infantile hypertrophic pyloric stenosis was noted by local pediatric surgeons. Results of a CDC investigation suggested a causal role of erythromycin in the cases of hypertrophic pyloric stenosis.133, 134 Erythromycin remains the recommended agent of choice for prophylaxis after pertussis exposure, but parents should be informed of the risk and signs of hypertrophic pyloric stenosis, and cases associated with erythromycin use should be reported to MedWatch.135
Other Bacterial Pathogens
Newborn infants are particularly prone to infection and disease following exposure to Mycobacterium tuberculosis. A cluster of multidrug-resistant M. tuberculosis infections was noted in three infants born during a 2-week period in one New York hospital.136 Investigation implicated an HCW who visited the nursery several times during that period. Pulmonary and extrapulmonary disease occurred in three infants 4 to15 months after exposure, highlighting the vulnerability of the newborn population.136 Tuberculosis screening of HCWs, ultraviolet lighting, and a high number of air exchanges appear to be effective methods in preventing nosocomial tuberculosis infection.137 The CDC’s “Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings” emphasizes (1) use of engineering controls and personal protective equipment, (2) risk assessments for the development of institutional tuberculosis control plans, (3) early identification and management of individuals with tuberculosis infection and disease, (4) tuberculosis screening programs for HCWs, (5) HCW education and training, and (6) evaluation of tuberculosis control programs.138
Fungi
Candida species are an increasingly important cause of nosocomial infection in NICU patients and have been estimated to account for 6.9% of bloodstream infections and 42% of urinary tract infections.20, 139 Prospective studies have estimated colonization rates with Candida to be 12% to 54% in low-birth-weight neonates,17, 140, 141, 142 and colonization has been associated with subsequent invasive disease.141 The mortality rate can be high in invasive candidiasis. In one study of 34 patients with fungemia due to Candida species, a case-fatality rate of 41% was reported.143 Risk factors for fungal infections in neonates are similar to risk factors for bacterial infections; low birth weight and gestational age are important predictors. In addition, a prospective, multicenter study of 2157 infants found that use of a third-generation cephalosporin, presence of a CVC, intravenously administered lipids, and H2 blocker therapy were associated with Candida colonization after adjusting for length of stay, birth weight of 1000g or less, and gestational age less than 32 weeks.14 Candida parapsilosis appears to be the most frequent species associated with nosocomial Candida infection in NICU infants. Both cross-contamination and maternal reservoirs are sources of nosocomial Candida albicans infection, as demonstrated in studies using molecular typing methods.144, 145, 146
Malassezia species, lipophilic yeasts, frequently colonize NICU patients. In one French study, 30 of 54 preterm neonates (56%) became colonized with Malassezia furfur.147 Malassezia pachydermatis, a zoonotic organism present on the skin and in the ear canals of healthy dogs and cats, also has been associated with nosocomial outbreaks in the NICU setting.147, 148 In one report, the outbreak appeared to be linked to colonization of HCWs’ pet dogs.147
Pichia anomala, or Hansenula anomala, a yeast found in soil and pigeon droppings, and on plants and fruits, also can colonize the human throat and gastrointestinal tract. In general, it is an unusual cause of nosocomial infection in neonates, but it was the cause of two reported outbreaks in this setting.149, 150 In both reports, carriage on the hands of HCWs appeared to be a factor.
Invasive mold infections are a rare cause of nosocomial infection in neonates, but when they occur, they are associated with high mortality rate. Aspergillus infections may manifest as pulmonary, central nervous system, gastrointestinal, or disseminated disease. A cutaneous presentation, with or without subsequent dissemination, appears to be the most common presentation for hospitalized premature infants without underlying immune deficiency.151, 152 Often, skin maceration is the presumed portal of entry. In a series of four patients who died of disseminated Aspergillus infection that started cutaneously, a contaminated device used to collect urine from the male infants was implicated.152 Similarly, contaminated wooden tongue depressors, used as splints for intravenous and arterial cannulation sites, were associated with cutaneous infection due to Rhizopus microsporus in four premature infants.153 In addition to preterm birth, use of broad-spectrum antimicrobial agents, steroid therapy, and hyperglycemia are thought to be risk factors for mold infection.
Even zoophilic dermatophytes have been described as a source of nosocomial infection in neonates. In one report, five neonatal cases in one unit were traced to an infected nurse and her cat.154 Prolonged therapy for both the nurse and her cat was necessary to clear their infections.
Viruses
Rotavirus
Although many pathogens can cause nosocomial gastroenteritis, rotavirus is responsible for 95% or more of viral infections in high-risk nurseries, including the NICU.20 In one longitudinal study, rotavirus infection developed during hospitalization in 95 of 194 neonates (49%).155 In this study, rotavirus was manifested as frequent and watery stools in term infants and as abdominal distention and bloody, mucoid stools in the preterm neonates.
A high titer of virus is excreted in stool of infected persons, and the organism is viable on hands and in the environment for relatively prolonged periods of time.156, 157 Attention to hand hygiene and disinfection of potential fomites are crucial in preventing spread of infection. This concept is illustrated by the results of one study in which rotavirus infection was associated with ungloved nasogastric tube feeding.157
Respiratory Viruses
Respiratory viruses including influenza A virus, parainfluenza virus, coronavirus, respiratory syncytial virus, and adenovirus have been reported to cause nosocomial infections in NICU patients.158, 159, 160, 161 Associated clinical findings include rhinorrhea, tachypnea, retractions, nasal flaring, rales, and wheezing, but illness also can be manifested as apnea, sepsis-like illness, and gastrointestinal symptoms.161, 162 Identified risk factors for acquisition vary from study to study but have included low birth weight, low gestational age, twin pregnancy, mechanical ventilation, and high CRIB score.159, 160, 161, 162 Contact and droplet transmission are the most common modes of spread of infection, again highlighting the importance of scrupulous hand hygiene in delivery of patient care for this population.
Enteroviruses
Numerous nursery and NICU outbreaks of enteroviral infection have been reported.163, 164 In the neonate with enteroviral infection, clinical manifestations can range from mild gastroenteritis to a severe and fulminant sepsis-like syndrome or meningitis/encephalitis. The latter presentation can be associated with a high mortality rate.164 In index cases, the patient may have acquired disease vertically, with subsequent horizontal spread leading to outbreaks164, 165; with other viral pathogens, virus can be shed into the stool for prolonged periods, enabling patient-to-patient transmission by the hands of HCWs when hand hygiene procedures are improperly performed.
Cytomegalovirus
Congenitally acquired cytomegalovirus (CMV) infection is a cause of morbidity and occasionally death, whereas postnatally acquired CMV infection follows a benign course in virtually all healthy term infants. Postnatal CMV infection, however, can cause considerable morbidity and death in premature infants.166 Hepatitis, neutropenia, thrombocytopenia, sepsis-like syndrome, pneumonitis, and development of chronic lung disease each have been associated with postnatal acquisition of CMV in premature infants.167, 168 With the routine use of CMV-seronegative blood products in these neonates, a majority of postnatal CMV infections appear to be acquired through breast milk.169 It has been estimated that transmission by this mode occurs in approximately 37% of breast-fed infants of mothers with CMV detected in breast milk.170 In one study, approximately 50% of these infants had clinical features of infection, and 12% presented with a sepsis-like syndrome. Nosocomial person-to-person transmission has been documented,171, 172 but the extent to which this occurs is controversial.173 At present, no proven, highly effective method is available for removing CMV from breast milk without destroying its beneficial components. Some data, however, suggest that freezing the breast milk before use may decrease the CMV titer, thereby limiting subsequent transmission.174
Herpes Simplex Virus
In a majority of cases, neonatal herpes simplex virus (HSV) infection is acquired vertically from the mother. Nursery transmission of HSV infection is rare but has been described.175, 176, 177 In each of these cases, HSV-1 was involved. In one infant, the source of virus was thought to be a patient’s father, who had active herpes labialis.175 Subsequent spread of virus from this first infant to a second infant was thought to have occurred by means of the hands of an HCW. In another report, the source of HSV for the index case, an infant who died of respiratory distress in whom evidence of HSV infection was found at postmortem examination of the brain, was unknown.176 The hands of HCWs were implicated in the spread of HSV to three subsequent cases, however. In another report, direct spread from an HCW was thought to be responsible for transmission of HSV to three infants over a period of approximately 3 years.177 Studies of adults with herpes labialis suggest a high frequency of recovery of virus from the mouth and the hands (78% and 67%, respectively).178 In this same study, HSV was shown to survive for 2 to 4 hours on skin, cloth, and plastic. Implementing contact precautions for infants with HSV and instructing HCWs with active herpes labialis regarding control measures, such as covering the lesion, not touching the lesion, and using strict hand hygiene, are reasonable means to prevent nosocomial transmission of HSV. If there are concerns that an HCW would be unable to comply with control measures or if the HCW has a herpetic whitlow, such persons should be restricted from patient contact.
Varicella-Zoster Virus
Nosocomial transmission of varicella in the NICU setting, although unusual, has been described.179 Large-scale outbreaks in nurseries and NICUs are rare, most probably because of the high rate of varicella-zoster virus (VZV) immunity in HCWs and pregnant women. Premature infants born at less than 28 weeks of gestation are unlikely to have received protective levels of VZV IgG from their mothers, so their potential risk is significant if an exposure occurs. Transmission is most likely to occur from an adult with early, unrecognized symptoms of varicella. In such instances, the potential risk for VZV-seronegative exposed infants and HCWs is substantial, especially if the patient in the index case is an HCW.180 For this reason, it is recommended that HCWs be screened for prior varicella infection by history, with subsequent immunization as indicated.
Hepatitis A
Hepatitis A is a rare cause of nosocomial infection in NICUs, but a number of outbreaks in this setting have been reported.181, 182, 183 In most instances, disease in neonates is clinically silent. Neonatal cases often are detected only through recognition of the symptomatic secondary adult cases. In one report, disease was acquired by patients in the index cases through blood transfusion from a donor with acute hepatitis A.183 Of note, the virus subsequently spread to another 11 infants, 22 nurses, and 8 other HCWs. Overall, hepatitis A affected 20% of the patients and 24% of the nurses. Lapses in infection control practices and the prolonged shedding of the virus in infants stool probably contributed to the rapid spread and high attack rate documented in the outbreak. Outbreaks such as this one are unlikely because of current blood product practices to eliminate transmissible agents from donor blood.
PREVENTION AND CONTROL
An effective infection control program that focuses on reducing risk on a prospective basis can decrease the incidence of nosocomial infections.184, 185 The principal function of such a program is to protect the infant and the HCW from risk of hospital-acquired infection in a manner that is cost-effective. Activities crucial to achieving and maintaining this goal include collection and management of critical data relating to surveillance for nosocomial infection, and direct intervention to interrupt the transmission of infectious diseases.22
Surveillance
Reducing the incidence of nosocomial infection for neonates must begin with surveillance for these events. Surveillance has been defined as “a comprehensive method of measuring outcomes and related processes of care, analyzing the data, and providing information to members of the health care team to assist in improving those outcomes.”186 Essential elements of a surveillance program include the following:
-
•
Defining the population and data elements as concisely as possible
-
•
Collecting relevant data using systematic methods
-
•
Consolidating and tabulating data to facilitate evaluation
-
•
Analyzing and interpreting data
-
•
Reporting data to those who can bring about change187
Surveillance systems necessarily vary, depending on the population; accordingly, a written plan, based on sound epidemiologic principles,187 should be in place to track rates of infection over time. Because new risks can emerge, such as new interventional technology or drugs, changing patient demographics, and new pathogens and resistance patterns, the plan should be reviewed and updated frequently.188 The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) recommends that hospitals have a written infection control plan that includes a description of prioritized risks; a statement of the goals of the infection control program; a description of the hospital’s strategies to minimize, reduce, or eliminate the prioritized risks; and a description of how the strategies will be evaluated. The JCAHO further recommends that hospitals identify risks for transmission and acquisition of infectious agents (Table 35–3) and formally review this analysis annually and whenever significant changes occur in any of the risk factors.189
Table 35-3.
Factors Influencing Transmission and Acquisition of Infectious Agents within a Hospital
| Geographic location and community environment of the hospital |
| Characteristics of the population served |
| Care, treatment, and services provided |
| Actions after analysis of the hospital’s infection prevention and control data |
Data from Joint Commission on Accreditation of Healthcare Organizations. Surveillance, Prevention and Control of Infection, 2005 Pre-publication edition. Oak Brook Terrace, Ill, Joint Commission on Accreditation of Healthcare Organizations, 2003, pp 1–11. Available at http://www.jcaho.org/accredited+organizations/patient+safety/infection+control/05_ic_std_hap.pdf.
The definitions provided by the CDC’s NNIS system are the most comprehensive and widely used set of case definitions for the outcomes of nosocomial infections.189 The system provides high-risk nursery–specific data collection methods as well as denominator data and allows external benchmarking of infection rates for this population.190, 191 The NNIS system defines a nosocomial infection as a localized or systemic process that results from adverse reaction to the presence of an infectious agent(s) or its toxin(s) and that was not present or incubating at the time of admission to the hospital. NNIS also recognizes as special situations, and defines as nosocomial, some infections in neonates that result from passage through the birth canal but do not become clinically apparent until several or more days after birth. It does not, however, consider infections that are known or proved to have been acquired transplacentally to be nosocomial.191
Distinction between maternal and hospital sources of infection is important, although difficult at times, because control measures designed to prevent acquisition from hospital sources will be ineffective in preventing perinatal acquisition of pathogens.192 Surveillance for infections in healthy newborns also is challenging because of the typically short length of stay. Infections can develop after discharge, and these are more difficult for infection control practitioners (ICPs) to capture. Methods for postdischarge surveillance have been developed, but because most neonatal infections that occur following discharge are noninvasive,193 such surveillance has not been widely implemented, because of concerns about the cost-effectiveness of these labor-intensive processes.
The ultimate goal of surveillance is to achieve outcome objectives (e.g., decreases in infection rates, morbidity, mortality, or cost).187 Baseline infection rates for an inpatient unit must be established so that the endemic rate of infection can be understood and addressed. In the NICU, concurrent surveillance (initiated while the infant is in the hospital) should be conducted by persons trained to collect and interpret clinical information. Typically, such persons are ICPs working closely with HCWs and using various data sources (Table 35–4).
Table 35-4.
Sources of Surveillance Data
| Admission records |
| Patient records |
| Closed medical records |
| Kardex |
| Temperature and vital signs records |
| Microbiology reports |
| Antimicrobial susceptibility reports |
| Verbal and written reports |
| Radiographic reports |
| Interviews with caregivers |
| Interviews with and observation of patient |
| Postdischarge reports |
| Autopsy reports |
Data from Lee TB, Baker OG, Lee JT, et al. Recommended practices for surveillance. Association for Professionals in Infection Control and Epidemiology, Inc. Surveillance Initiative Working Group. Am J Infect Control 26:277–288, 1998.
Using NNIS or other accepted definitions, the ICP should collect data regarding cases of nosocomial infection in the NICU population as well as population-specific denominator data. Denominators must be carefully chosen to represent the population at risk. Attempts to stratify risk should take into account both underlying infant-specific risks and those resulting from therapeutic or diagnostic interventions.186 Risk stratification techniques that attempt to control for distribution of risk have included severity of illness score, intensity of care required, and birth weight.74 Because the risk for developing nosocomial infection is greater for lower-birth-weight infants,48 the NNIS system breaks down data collection and analysis into birth weight categories (Tables 35–5 and 35–6).191, 194 The use of invasive devices, however, also is an important factor to consider. The appropriate denominator for an infection related to the use of a medical device, such as a CVC-related primary bloodstream infection, according to NNIS, would be total device days for the population during the surveillance period.
Table 35-5.
National Nosocomial Infections Surveillance NICU Birth Weight Categories
| ≤1000 g |
| 1001–1500 g |
| 1501–2500 g |
| >2500 g |
| NICU, neonatal intensive care unit. |
Data from Centers for Disease Control and Prevention, Division of Health Care Quality Promotion. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2003, issued August 2003. Am J Infect Control 30:481–498, 2003.
Table 35-6.
Distribution of Device-Associated Infection Rates by Birth Weight Categorya
| Birth Weight (g) |
Pooled Mean |
|
|---|---|---|
| Umbilical and CR-BSIb | VAPc | |
| ≤1000 | 10.6 | 3.3 |
| 1001–1500 | 6.4 | 2.5 |
| 1501–2500 | 4.1 | 2.1 |
| >2500 | 3.7 | 1.4 |
| NICU, neonatal intensive care unit; VAP, ventilator-associated pneumonia. | ||
NICU component of reported data, January 1995 to June 2003 (VAP data are for January 2002 through June 2003 only).
Number of umbilical and central line–related (CR) bloodstream infections (BSIs) × 1000/number of umbilical and central line days.
Number of VAP cases × 1000/number of ventilator days.
Data from Centers for Disease Control and Prevention, Division of Health Care Quality Promotion. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2003, issued August 2003. Am J Infect Control 30:481–498, 2003.
The formula generally used for calculating nosocomial infection rates is (x/y)k, where x equals the number of events (infections) over a specific time period, y equals the population at risk for development of the outcome, and k is a constant and a multiple of 10. Rates can be expressed as a percentage (k = 100), although device-related infections usually are expressed as events per 1000 device days (k = 1000). A value should be selected for k that results in a rate greater than 1.187
Because use of invasive devices is such a significant risk factor both for bloodstream infection and ventilator-associated pneumonia, assessing NICU practices with device use may be warranted. NNIS provides a benchmark for NICU device utilization broken down into birth weight categories. An NICU device utilization ratio can be calculated using the following formula:
In those units with device utilization ratios above the NNIS 90th percentile, investigation into the practices surrounding use of invasive devices may be warranted.195 Calculating monthly and annual rates to employ as benchmarks can assist in identification of a potential problem in device-related procedures.
Surveillance data must be arranged and presented in a way that facilitates interpretation, comparison both directed internally and with comparable external benchmarks, and dissemination within the organization. Quality improvement tools (e.g., control and run charts) can be useful for these purposes. Statistical tools should be used to determine the significance of findings, although statistical significance should always be balanced with the evaluation of clinical significance.187 External benchmarking through interhospital comparison is a valuable tool for improving quality of care196, 197 but should be performed only when surveillance methodologies (e.g., case definitions, case finding, data collection methods, intensity of surveillance)187 can reasonably be assumed to be consistent between facilities.
Few overall infection rates in NICUs are available, but a small study done in 17 children’s hospitals performing NICU nosocomial infection surveillance reported a median nosocomial infection rate of 8.9 infections per 1000 patient days (range, 4.6 to 18.1).198 NNIS does not provide a benchmark for overall infection rates within NICUs. Instead, NNIS provides birth weight–stratified device-associated infection rates for umbilical and central intravascular line–associated bloodstream infections. The most recent rates for catheter-related bloodstream infections (137 to 143 NICUs reporting) and ventilator-associated pneumonias (78 to 96 NICUs reporting) are summarized in Table 35–6.194
Once arranged and interpreted, nosocomial infection data must be shared with personnel who can effect change and implement infection control interventions. Written reports summarizing the data and appropriate control charts should be provided to the facility’s infection control committee, unit leaders, and members of the hospital administration on an ongoing basis. The interval between reports is determined by the needs of the institution. In addition to formal written reports, face-to-face reports are appropriate in the event of identification of a serious problem or an outbreak. ICPs can serve as consultants to assist NICU or neonatology service leaders in addressing infection rate increases or outbreak management.
Outbreak (Epidemic) Investigation
Surveillance activities typically identify endemic nosocomial infections (i.e., those infections that represent the usual level of disease within the nursery or NICU).199 Although the rate can fluctuate over time, in the absence of interventions that successfully reduce risk of infection, the difference rarely is statistically significant. Establishing an NICU’s endemic infection rate and expected variation around that rate allows the ICP to rapidly identify unusual increases in rates that may indicate on outbreak (epidemic) of a particular infection. Using baseline surveillance data along with aggregate data from sources such as the NNIS system allows the ICP to develop meaningful threshold rates for initiating outbreak investigation.188 Alternatively, HCWs can be the first to sense an increase in infections, which then can be confirmed or refuted by surveillance data.200 Even a single case of infection due to an unusual and potentially dangerous pathogen (e.g., Salmonella) can constitute the index case for a subsequent outbreak and thus merits rapid and comprehensive investigation. Outbreaks may need to be reported to health authorities, depending on local and state requirements as well as the organism involved.
Numerous studies have described nursery and NICU epidemics caused by a variety of pathogens (Table 35–7), and most such epidemics have required the coordinated efforts of ICPs, NICU leadership, staff, and hospital administration for resolution.79, 106, 115, 136, 157, 161, 162, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212 Outbreak investigation and intervention should be approached systematically, applying sound epidemiologic principles. In general, the process should include the following199, 200:
Confirming that an outbreak exists, by comparing the outbreak infection rate with baseline data (or with rates reported in the literature if baseline data are not available), and communicating concerns to stakeholders within the institution (and to those in other agencies if notification of health authorities is necessary)
Assembling the appropriate personnel to assist in developing a case definition and in planning immediate measures to prevent new cases
Performing active surveillance using the case definition to search for additional infections and collecting critical data and specimens
Characterizing cases of infection by person, place, and time, including plotting of an epidemic curve (to facilitate identification of shared risk factors among involved patients, such as invasive devices, proximity to other infected patients or temporal association with infection in such patients, common underlying diagnoses, shared medical or nursing staff, surgery, and medications, including antimicrobial agents)
Formulating a working hypothesis and testing this hypothesis (if the severity of the problem warrants this level of study, and provided that the institution has and can commit the necessary resources), with use of analytic approaches, including case-control and cohort studies, as appropriate to determine the likely cause of the outbreak
Instituting and evaluating control measures, which can be implemented anywhere in the foregoing process (more directed measures become possible as more is learned about the outbreak, and efficacy of control measures can be judged on whether the outbreak resolves, as indicated by return of number of cases to endemic levels or by cessation of occurrence of infections)
Reporting findings to appropriate personnel, including unit staff, hospital administration, and public health authorities (if involved in management of the outbreak), in comprehensive written reports, including summaries of how the outbreak was first recognized, study and analysis methods used, interventions implemented to resolve the epidemic, results, and a discussion of any other important outcomes or surveillance and control measures identified
Table 35-7.
Reported Nursery Outbreaks of Infection
| Causative Organism | Source | Reference | Year | Location |
|---|---|---|---|---|
| Staphylococcus aureus (pyoderma) | Hospital staff | 212 | 2002 | Taipei, Taiwan |
| Staphylococcus aureus | Skin barrier paste (Stomahesive) | 206 | 2000 | Leeds, UK |
| MRSA | Horizontal transmissiona? | 207 | 2001 | Washington, DC |
| Enterococcus faecium (VRE) | Unknown | 79 | 2001 | Omaha |
| Clostridium species | Horizontal transmission? | 210 | 2002 | Manitoba, Canada |
| Serratia marcescens | Horizontal transmission | 204 | 1998 | Leipzig, Germany |
| S. marcescens | Milk bottles | 115 | 2002 | Zurich |
| Enterobacter sakazakii | Powdered milk formula | 201 | 1998 | Brussels |
| Klebsiella pneumoniae, antibiotic-resistant | Environment, breast milk, horizontal transmission | 106 | 2001 | London |
| Acinetobacter species | Air conditioners | 202 | 1996 | Bahamas |
| Pseudomonas aeruginosa | Unknown | 203 | 1999 | Maryland |
| Chryselbacterium meningosepticum | Sink taps | 211 | 1996 | London |
| Salmonella enterica | Horizontal transmission | 209 | 1999 | Rio de Janeiro |
| Tuberculosis, multidrug-resistant | Hospital staff? | 136 | 1998 | New York |
| Adenovirus type 8 | Horizontal transmission? | 205 | 1998 | Heidelberg, Germany |
| Parainfluenza virus type 3 | Horizontal transmission? | 161 | 1996 | Winnipeg, Canada |
| Influenza A virus | Unknown | 162 | 1999 | Barcelona, Spain |
| Respiratory syncytial virus | Unknown | 208 | 2002 | Riyadh, Saudi Arabia |
| Rotavirus | Environment | 157 | 2002 | Holland |
| MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci. | ||||
Horizontal transmission refers to indirect contact transmission by contaminated equipment or health care workers’ hands.
Interventions used to control and limit outbreaks usually have consisted of isolation and cohorting of infected or colonized infants to prevent transmission of organisms. Transmission-based precautions, a system developed by the CDC, can be used to determine the most effective barrier precautions to use with affected patients. Cohorting, or placing infants infected or colonized with the outbreak organism together in geographically segregated areas and assigning dedicated staff and equipment to their care, also has been used successfully to halt outbreaks in nurseries and NICUs. In extreme cases, closure of an NICU to admissions has been necessary to bring an outbreak under control.57, 106, 161
Every attempt should be made to identify the source of a nursery outbreak, although this is not always possible. Sources implicated in NICU outbreaks have included medications, equipment, and enteral feeding solutions; person-to-person transmission and environmental reservoirs also have been reported.102, 106, 157, 201, 202, 213 Efforts to identify the source may include culturing of specimens from HCWs, equipment, and the environment, although careful consideration should be given to the potential benefits before initiating these measures. Culture of samples from the environment and equipment, in view of the vast number of objects that could be contaminated, usually is not helpful in identifying the source of an outbreak unless specific case characteristics or microbiologic data strongly suggest the location. Culture of specimens obtained from HCWs when person-to-person transmission is suspected may be more likely to identify the source of an outbreak, but it must be remembered that an HCW whose culture specimen yields the outbreak organism may have been transiently colonized while working with an affected infant, rather than constituting the source of the infection. Management of culture-positive HCWs (possible furlough, treatment, and return to work criteria) should be planned in advance of widespread culture surveillance and should involve supervisors of affected employees and occupational health services.200
Standard and Transmission-Based Precautions in the Nursery
The most widely accepted guideline for preventing the transmission of infections in hospitals was developed by the CDC. Most recently revised in 1996, the system contains two tiers of precautions. The first and most important, standard precautions, was designed for the management of all hospitalized patients regardless of their diagnosis or presumed infection status. The second, transmission-based precautions, is intended for patients documented or suspected to be infected or colonized with highly transmissible or epidemiologically important pathogens for which additional precautions to interrupt transmission are needed.25
Standard precautions are designed to reduce the risk of transmission of microorganisms from both recognized and unrecognized sources and are to be followed for the care of all patients, including neonates. They apply to blood; all body fluids, secretions, and excretions except sweat; nonintact skin; and mucous membranes. Components of standard precautions include hand hygiene and wearing gloves, gowns, and masks and other forms of eye protection.
Hand hygiene plays a key role for caregivers in the reduction of nosocomial infection for patients27, 214 and in prevention of nosocomial or health care–associated infections. Hand hygiene should be performed before and after all patient contacts; before donning sterile gloves to perform an invasive procedure; after contact with blood, body fluids or excretions, mucous membranes, nonintact skin, and wound dressings; in moving from a contaminated body site to a clean body site during patient care (i.e., from changing a diaper to performing mouth care); after contact with inanimate objects in the immediate vicinity of the patient; after removing gloves; and before eating and after using the restroom.131 When hands are visibly soiled or contaminated with proteinaceous materials, blood, or body fluids, and after using the restroom, hands should be washed with antimicrobial soap and water. Soaps containing 2% to 4% chlorhexidine gluconate or 0.3% triclosan156 are recommended for hand washing in nurseries.192 When hands are not visibly soiled, alcohol-based hand rubs, foams, or gels are an important tool for hand hygiene. Compared with washing with soap and water, use of the alcohol-based products is at least as effective against a variety of pathogens and requires less time, and these agents are less damaging to skin. The CDC “Guideline for Hand Hygiene in the Health Care Setting” calls for use of alcohol hand rubs, foams, or gels as the primary method to clean hands, except when hands are visibly soiled.131 Programs that have been successful in improving hand hygiene and decreasing nosocomial infection have used multidisciplinary teams to develop interventions focusing on use of the alcohol rubs in the setting of institutional commitment and support for the initiative.27, 215
HCWs should wash hands and forearms to the elbows on arrival in the nursery. A 3-minute scrub has been suggested,216 but consensus on optimal duration of initial hand hygiene is lacking. At a minimum, the initial wash should be long enough to ensure thorough washing and rinsing of all parts of the hands and forearms. Routine hand washing throughout care delivery should consist of wetting the hands, applying product, rubbing all surfaces of the hands and fingers vigorously for at least 15 seconds, rinsing, and patting dry with disposable towels.131 Wearing hand jewelry has been associated with increased microbial load on hands. Whether this results in increased transmission of pathogens is not known. Many experts, however, recommend that hand and wrist jewelry not be worn in the nursery.217, 218 In addition, the CDC guideline states that staff who have direct contact with infants in NICUs should not wear artificial fingernails or nail extenders.131 Only natural nails kept less than 1/4 inch long should be allowed.
Clean, nonsterile gloves are to be worn whenever contact with blood, body fluids, secretions, excretions, and contaminated items is anticipated. The HCW should change gloves when moving from dirty to clean tasks performed on the same patient, such as after changing a diaper and before suctioning a patient, and whenever they become soiled. Because hands can become contaminated during removal of gloves, and because gloves may have tiny, unnoticeable defects, wearing gloves is not a substitute for hand hygiene. Hand hygiene must be performed immediately after glove removal.25
Personnel in nurseries including the NICU historically have worn cover gowns for all routine patient contact. The practice has not been found to reduce infection or colonization in neonates and is unnecessary.219, 220 Instead, CDC guidelines recommend nonsterile, fluid-resistant gowns to be worn as barrier protection when soiling of clothing is anticipated and in performing procedures likely to result in splashing or spraying of body substances.25 Possible examples of such procedures in the NICU are placing an arterial line and irrigating a wound. The Perinatal Guidelines of the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists recommend that a long-sleeved gown be worn over clothing when a neonate is held outside the bassinette by nursery personnel.221
Nonsterile masks, face shields, goggles, and other eye protectors are worn in various combinations to provide barrier protection and should be used during procedures and patient care activities that are likely to generate splashes or sprays of body substances and fluids.25
Standard precautions also require that reusable patient care equipment be cleaned and appropriately reprocessed between patients; that soiled linen be handled carefully to prevent contamination of skin, clothing, or the environment; that sharps (i.e., needles, scalpels) be handled carefully to prevent exposure to blood-borne pathogens; and that mouthpieces and other resuscitation devices be used, rather than mouth-to-mouth methods of resuscitation.25
In addition to standard precautions, which must be used for every patient, the CDC recommends transmission-based precautions when the patient is known or suspected to be infected or colonized with epidemiologically important or highly transmissible organisms. Always used in addition to standard precautions, transmission-based precautions comprise three categories: contact precautions, droplet precautions, and airborne precautions.
Contact precautions involve the use of barriers to prevent transmission of organisms by direct or indirect contact with the patient or contaminated objects in the patient’s immediate environment.25 Sources of indirect contact transmission in nurseries can include patient care equipment such as monitor leads, thermometers, isolettes, breast pumps,186 toys, and instruments and contaminated hands.222
The patient requiring contact precautions should be placed in a private room whenever possible but, after consultation with an infection control practitioner, can be cohorted with a patient infected with the same microorganism but no other infection.25 Many nurseries, however, have few if any isolation rooms. The American Academy of Pediatrics states that infected neonates requiring contact precautions can be safely cared for without an isolation room if staffing is adequate to allow appropriate hand hygiene, a 4- to 6-foot-wide space can be provided between care stations, adequate hand hygiene facilities are available, and staff members are well trained regarding infection transmission modes.221
HCWs should wear clean, nonsterile gloves when entering the room or space of a patient requiring contact precautions and should wear a cover gown when their clothing will have contact with the infant, environmental surfaces, or items in the infant’s area. A cover gown also should be worn when the infant has excretions or secretions that are not well contained, such as diarrhea or wound drainage, which may escape the diaper or dressing. Infant care equipment should be dedicated to the patient if possible so that it is not shared with others.25
Examples of conditions in the neonate that require contact precautions include neonatal mucocutaneous herpes simplex virus infection, respiratory syncytial virus infection, varicella (also see airborne precautions), infection or colonization with a resistant organism such as MRSA or a multiple drug–resistant gram-negative bacillus, and congenital rubella syndrome.
Droplet precautions are intended to reduce the risk of transmission of infectious agents in large-particle droplets from an infected person. Such transmission usually occurs when the infected person generates droplets during coughing, sneezing, or talking, or during procedures such as suctioning. These relatively large droplets travel only short distances and do not remain suspended in the air, but can be deposited on the conjunctiva, nasal mucosa, and/or mouth of persons working within 3 feet of the infected patient.25 Patients requiring droplet precautions should be placed in private rooms (see earlier discussion of isolation rooms in nurseries in the paragraph on contact precautions), and staff should wear masks when working within 3 feet of the patient.25 Examples of conditions in the neonate that necessitate droplet precautions are pertussis and invasive N. meningitidis infection.
Airborne precautions are designed to reduce the risk of airborne transmission of infectious agents.25 Because of their small size, airborne droplet nuclei and dust particles containing infectious agents or spores can be widely spread on air currents or through ventilation systems and inhaled by or deposited on susceptible hosts. Special air-handling systems and ventilation are required to prevent transmission. Patients requiring airborne precautions should be placed in private rooms in negative air-pressure ventilation with 6 to 12 air changes per hour. Air should be externally exhausted or subjected to high-efficiency particulate air (HEPA) filtration if it is recirculated.222
Examples of conditions in the neonate for which airborne precautions are required are varicella-zoster virus infections and measles. Susceptible HCWs should not enter the rooms of patients with these viral infections. If assignment cannot be avoided, susceptible staff members should wear masks to deliver care. If immunity has been documented, staff members need not wear masks.222 Airborne precautions also are required for active pulmonary tuberculosis, and although neonates are rarely contagious, the CDC recommends isolating patients while they are being evaluated.213 A more important consideration is the need to isolate the family of a suspected tuberculosis patient until an evaluation for pulmonary tuberculosis has been completed, because the source of infection frequently is a member of the child’s family.223, 224
Physical Environment
Before the 1990s, well-baby nurseries and many NICUs were constructed as large, brightly lit open wards with rows of incubators surrounded by equipment. Sinks could be provided in such rooms only around the periphery, limiting access to hand hygiene facilities for staff and families. In these NICUs, parents’ time with their infant was severely restricted, and the units were designed for the convenience and function of the HCW.225 More recently, perinatal care professionals have come to understand that neonates (and especially preterm infants) can benefit from a quiet, soothing atmosphere and protection from unnecessary light, noise, handling, uncomfortable positioning, and sleep disruptions.226
If infants are kept in a central nursery rather than rooming-in with mothers, at least 30 square feet of floor space should be provided per neonate, and bassinets should be at least 3 feet apart.216 Teams designing units delivering higher levels of perinatal care, including NICUs, should plan individual bed areas large enough for families to stay at the bedside for extended periods of time without interfering with the staff’s ability to care for the child. If individual rooms cannot be provided, at least 150 square feet of floor space should be allowed for each neonate in an NICU, incubators or overhead warmers should be separated by at least 6 to 8 feet, and aisles should be at least 8 feet wide.216, 227
A scrub sink with foot, knee, or touchless (electronic sensor) controls should be provided at the entrance to every nursery and should be large and deep enough to control splashing. Sinks in patient care areas should be provided at a minimum ratio of 1 sink for at least every 6 to 8 stations in the well-baby nursery and 1 sink for every 3 or 4 stations in higher-level nurseries, including the NICU.216 Every bed position should be within 20 feet of a hand-washing sink and accessible for children and persons in wheelchairs.227 For NICUs composed of individual rooms, a hand-washing sink should be located in each room near the door to facilitate hand hygiene on entering and leaving the room.
Environmental surfaces should be designed so that they are easy to clean and do not harbor microorganisms. Sink taps and drains, for instance, have been implicated in outbreaks of infection.228, 229 Installing sinks with seamless construction may minimize this risk by decreasing areas where water can pool and microorganisms proliferate. Faucet aerators have been implicated in outbreaks of infection and should be avoided in the intensive care unit.230 Although carpeting can reduce noise levels in a busy NICU, the CDC “Guidelines for Environmental Infection Control in Health-Care Facilities” recommend against use of carpeting in areas where spills are likely, including intensive care units. The guidelines further recommend against upholstered furniture in NICUs.231 If, for reasons of noise reduction and developmentally appropriate care, porous surfaces such as carpeting and cloth upholstery are selected for the NICU, cleaning must be performed carefully. Carpet should be vacuumed regularly with equipment fitted with HEPA filters, and upholstered furniture should be removed from inpatient areas to be cleaned.
Attention also should be paid to air-handling systems. According to the Perinatal Guidelines, minimal standards for inpatient perinatal care areas include six air changes per hour, and a minimum of two changes should consist entirely of outside air. Air delivered to the NICU should be filtered with at least 90% efficiency. In addition, nurseries should include at least one isolation room capable of providing negative pressure vented to the outside, observation windows with blinds for privacy, and the capability for remote monitoring.227, 232
General Housekeeping
Floors and other horizontal surfaces should be cleaned daily by trained personnel using Environmental Protection Agency (EPA)–registered hospital disinfectants/detergents. These products (including phenolics and other chemical surface disinfectants) must be prepared in accordance with manufacturers’ recommendations and used carefully to avoid exposing neonates to these products. Phenolics should not be used on surfaces that come in direct contact with neonates’ skin.231 High-touch areas, such as counter tops, work surfaces, doorknobs, and light switches, may need to be cleaned more frequently because they can be heavily contaminated during the process of delivering care. Hard, nonporous surfaces should be “wet dusted” rather than dry dusted, to avoid dispersing particulates into the air, and then disinfected using standard hospital disinfectants.231 Sinks should be scrubbed daily with a disinfectant detergent. Walls, windows, and curtains should be cleaned regularly to prevent dust accumulation, but daily cleaning is not necessary unless they are visibly soiled.
Bassinets and incubators should be cleaned and disinfected between infants, but care must be taken to rinse cleaning products from surfaces with water before use. Care units should not be cleaned with phenolics or other chemical germicides during an infant’s stay. Instead, infants who remain in the nursery for long periods of time should periodically be moved to freshly cleaned and disinfected units.231
Patient care equipment must be cleaned, disinfected, and, when appropriate, sterilized between patients. Sterilization (required for devices that enter the vascular system, tissue, or sterile body cavities) and higher levels of disinfection (required for equipment that comes in contact with mucous membranes or that has prolonged or intimate contact with the newborn’s skin) must be performed under controlled conditions in the central processing department of the hospital. Examples of patient care equipment that require these levels of processing are endotracheal tubes, resuscitation bags, and face masks.216, 232, 233 Low-level disinfection is required for less critical equipment, such as stethoscopes or blood pressure cuffs, and usually can be performed at point of use (e.g., the bedside), although this type of equipment should be dedicated to individual patients whenever possible.
Linens
Requirements for linen handling and management for neonates do not vary appreciably from those for other hospitalized patients. Although soiled linen can contain large numbers of organisms capable of causing infections, transmission to patients appears to be rare. Studies suggesting linen as a source of infection often have failed to confirm it as the source of infection.234 At least one report, however, has implicated linen in the transmission of group A streptococci.85 Investigation of this outbreak revealed that clothing worn by the neonates was being washed in the local hospital “mini laundry,” rather than being processed under the usual laundry contract. Investigation of the dryers revealed extensive contamination with the outbreak organism. This case illustrates the importance of having standard hospital laundry protocols and ensuring that appropriate water and dryer temperatures are maintained. When such protocols are followed, the mechanical actions of washing and rinsing, combined with hot water and/or the addition of chemicals such as chlorine bleach, and a final commercial dryer and/or ironing step significantly reduce bacterial counts.235, 236 Few hospitals in the United States use cloth diapers, but regardless of type used, soiled diapers should be carefully bagged in plastic and removed from the unit every 8 hours.216
Health Care Workers
HCWs caring for neonates have the potential both to transmit infections to infants and to acquire infections from patients. Educating HCWs about infection control principles is crucial to preventing such transmission. Hospitals should provide education about infection control policies, procedures, and guidelines to staff in all job categories during new employee orientation and on a regular basis throughout employment. The content of this education should include hand hygiene, principles of infection control, the importance of individual responsibility for infection control, and the importance of collaborating with the infection control department in monitoring and investigating potentially harmful infectious exposures and outbreaks.
Transmission of infectious organisms between patients and HCWs has been well documented. Several studies have indicated that a high proportion of HCWs acquire RSV (34% to 56%) when working with infected children, and these workers appear to be important in the spread of the illness within hospitals.237, 238, 239 Although 82% of the infected HCWs in one of these RSV studies were asymptomatic, staff should be aware of the importance of self-screening for communicable disease. They should be encouraged to report personal infectious illnesses to supervisors, who in turn should report them to occupational health services and infection control. In general, HCWs with respiratory, cutaneous, mucocutaneous, or gastrointestinal infections should not deliver direct patient care to neonates.216 In addition, seronegative staff members exposed to illnesses, such as varicella and measles, should not work during the contagious portion of the incubation period.232
Staff members with HSV infection rarely have been implicated in transmission of the virus to infants and thus do not need to be routinely excluded from direct patient care. Those with herpes labialis or cold sores should be instructed to cover the lesions and not to touch their lesions, and to comply with hand hygiene policies. Persons with genital lesions also are unlikely to transmit HSV so long as hand hygiene policies are followed. However, HCWs who are unlikely or unable to comply with the infection control measures and those with herpetic whitlow should not deliver direct patient care to neonates until lesions have healed.240
Acquisition of CMV often is a concern of pregnant HCWs because of the potential effect on the fetus. Approximately 1% of newborn infants in most nurseries and a higher percentage of older children (up to 70% of children 1 to 3 years of age in child-care centers) excrete CMV without clinical manifestations.241 The risk of acquiring CMV infection has not been shown to be higher for HCWs than for the general population.242, 243 For this reason, pregnant caregivers need not be excluded from the care of neonates suspected to be shedding CMV. They should be advised of the importance of standard precautions.
HCWs in well-baby nurseries and NICUs should be as free from transmissible infectious diseases as possible,216 and ensuring that they are immune to vaccine-preventable diseases is an essential part of a personnel health program. The CDC recommends several immunizations for health care personnel (Table 35–8).
Table 35-8.
Immunizing Agents Strongly Recommended for Health Care Workers
| Vaccine | Recommendation |
|---|---|
| Hepatitis B recombinant vaccine | Vaccinate all HCWs at risk of exposure to blood and body fluids. |
| Influenza vaccine | Vaccinate HCWs annually. |
| Measles live-virus vaccine | Vaccine should be considered for all HCWs, including those born before 1957, who have no proof of immunity (receipt of 2 doses of live vaccine on or after first birthday, physician-diagnosed measles, or serologic evidence of immunity). |
| Mumps live-virus vaccine | HCWs believed to be susceptible can be vaccinated; adults born before 1957 can be considered immune. |
| Rubella live-virus vaccine | HCWs, both male and female, who lack documentation of receipt of vaccine on or after first birthday or serologic evidence of immunity should be vaccinated; adults born before 1957 can be considered immune, except women of childbearing age. |
| Varicella-zoster live-virus vaccine | HCWs without a reliable history of varicella or serologic evidence of varicella immunity should be vaccinated. |
| HCW, health care worker. | |
Data from Bolyard EA, Tablan OC, Williams WW, et al. Guideline for infection control in health care personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 19:407–463, 1998.
Staffing levels in a patient care setting also can affect patient outcomes. A number of studies suggest that as patient-to-nurse ratios in intensive care units increase, so do nosocomial infections and mortality rates.47, 132, 244 Although optimal staffing ratios have not been established for NICUs and will vary according to characteristics of individual units, one study demonstrated that the incidence of clustered S. aureus infections was 16 times higher after periods when the infant-to-nurse ratio exceeded 7:1. Decreased compliance with hand hygiene during a period of understaffing frequently is cited as contributing to nosocomial infection rate increases.98 Further study is necessary to determine best practice surrounding staffing levels in NICUs.
Family-Centered Care: Parents and Visitors to the Newborn Infant
The first NICUs in the late 1960s grouped infants together in large, brightly lit rooms with incubators placed in rows. Parents were allowed very little time with their babies and even less physical contact. In the decades since, it has been recognized that “the parent is the most important caregiver and constant influence in an infant’s life”225 and that HCWs working in NICUs should encourage parents to become involved in the nonmedical aspects of their child’s care. Principles of family-centered care also include liberal NICU visitation for relatives, siblings, and family friends and the involvement of parents in the development of nursery policies and programs that promote parenting skills.226
Care must be taken, however, to minimize risk of infection for the neonate. Mothers can transmit infections to neonates both during delivery and post partum, although separation of mother and newborn rarely is indicated. In the absence of certain specific infections, mothers, including those with postpartum fever not attributed to a specific infection, should be allowed to handle their infants if the following conditions are met:
-
•
They feel well enough.
-
•
They wash their hands well under supervision.
-
•
A clean gown is worn.
-
•
Contact of the neonate with contaminated dressings, linen, clothing, or pads is avoided.245
A mother with a transmissible illness not requiring separation from her infant should be carefully educated about the mode of transmission and precautions necessary to protect her infant. Personal protective equipment, such as cover gowns, gloves, and masks, and hand hygiene facilities should be readily available to her, and she should perform hand hygiene and don a long-sleeved cover gown before handling her infant. If wounds or abscesses are present, drainage should be contained within a dressing. If drainage cannot be completely contained, separation from the infant may be necessary. Care should be taken to prevent the infant from coming in contact with soiled linens, clothing, dressings, or other potentially contaminated items. The mother with active genital HSV lesions need not be separated from her infant if the foregoing precautions are taken. Those with herpes labialis should not kiss or nuzzle their infants until lesions have cleared; lesions should be covered and a surgical mask may be worn until the lesions are crusted and dry, and careful hand hygiene should be stressed.
Mothers with viral respiratory infections should be made aware that many of these illnesses are transmitted by contact with infected secretions as well as by droplet spread, that soiled tissues should be disposed of carefully, and that hand hygiene is critical to transmission prevention. Masks can be worn to reduce the risk of droplet transmission.221, 232
As previously mentioned, although very few infections require separation of mother and infant, women with untreated active pulmonary tuberculosis should be separated from their infants until they no longer are contagious. Mothers with group A streptococcal infections, especially when involving draining wounds, also should be isolated from their infants until they no longer are contagious. Less certain is the necessity of separating mothers with peripartum varicella (onset of infection within 5 days before or 2 days after delivery) from their uninfected infants. The Perinatal Guidelines recommend that such infants remain with their mothers after receiving varicella-zoster immune globulin (VZIG) but caution that infant and mother must be carefully managed in airborne and contact precautions245 to prevent transmission within the nursery. Some experts recommend separating these mothers from their infants until all lesions are dried and crusted.246
Breast-feeding
Numerous studies support the value of human milk for infants (see Chapter 5). Besides providing optimal nutritional content for infants, it has been shown to be associated with a lower incidence of infections and sepsis in the first year of life.16, 247 Although contraindications to breast-feeding are few, mothers who have active untreated tuberculosis, human immunodeficiency virus (HIV) infection, breast abscesses (as opposed to simple mastitis that is being treated with antimicrobial therapy), or HSV lesions around the nipples should not breast-feed. Mothers who are hepatitis B surface antigen positive may breast-feed, because ingestion of an infected mother’s milk has not been shown to increase the risk of transmission to her child, but the infant must receive hepatitis B virus immune globulin (HBIG) and vaccine immediately after birth.248 Because systemic disease may develop in preterm infants with low concentrations of transplacentally acquired antibodies to CMV following ingestion of milk of CMV-seropositive mothers, decisions regarding breast-feeding should consider the benefits of human milk versus the risk of CMV transmission. Freezing breast milk has been shown to decrease viral titers but does not eliminate CMV; pasteurization of human milk can inactivate CMV. Either method may be considered in attempts to decrease risk of transmission for breast-feeding NICU neonates.249
Neonates in the NICU frequently are incapable of breast-feeding because of maternal separation, unstable respiratory status, and immaturity of the sucking reflex. For these reasons, mothers of such infants must use a breast pump to collect milk for administration through a feeding tube. Pumping, collection, and storage of breast milk create opportunities for contamination of the milk, and for cross-infection if equipment is shared between mothers. Several studies have demonstrated contamination of breast pumps, contamination of expressed milk that had been frozen and thawed, and higher levels of stool colonization with aerobic bacteria in infants fed precollected breast milk.16, 250, 251
Consensus is lacking on the safe level of microbiologic contamination of breast milk, and most expressed breast milk contains normal skin flora. Although breast milk containing greater than 100CFU/mL of gram-negative bacteria has been reported to cause feeding intolerance and to be associated with suspected sepsis, routine bacterial culturing of expressed breast milk is not recommended.249, 250 Instead, efforts to ensure safety of expressed milk should focus on optimal collection, storage, and administration techniques. Cleaning and disinfection of breast pumps should be included in educational material provided to nursing mothers (Table 35–9). In addition, mothers should be instructed to perform hand hygiene and cleanse nipples with cotton and plain water before expressing milk in sterile containers.192, 249
Table 35-9.
Collection and Storage of Expressed Breast Milk
| Each mother is supplied with a personal pumping kit. |
| Nursing staff instruct mothers in techniques of milk expression and appropriate procedures for cleaning breast pump parts: |
| Wipe all horizontal surfaces at the pumping station with hospital disinfectant before and after pumping. |
| Wash hands with soapy water before and after pumping. |
| Wash all parts of the breast pump kit that have been in contact with milk in hot water and dish detergent or in a dishwasher. |
| Expressed milk is collected in sterile, single-use plastic (polycarbonate or polypropylene) containers. |
| Breast milk containers are labeled with infant’s name and the date and time of collection. |
| Administration containers (bottle or syringe) are similarly labeled when breast milk is transferred from collection containers. |
| All HCWs wear gloves when handling and administering breast milk. |
| Two persons check the labeled administration container against the infant’s hospital identification band before administering breast milk (may be two HCWs or one HCW and a family member). |
| HCW, health care worker. |
From Infection Control Policy, Children’s Hospital and Regional Medical Center, Seattle, 2003.
Expressed breast milk can be refrigerated for up to 48 hours and can be safely frozen (–20°C ± 2°C [–4°F ± 3.6°F]) for up to 6 months.192 It can be thawed quickly under warm running water (avoiding contamination with tap water) or gradually in a refrigerator. Exposure to high temperatures, as may be experienced in a microwave, can destroy valuable components of the milk. Thawed breast milk can be stored in the refrigerator for up to 24 hours before it must be discarded. To avoid proliferation of microorganisms, milk administered through a feeding tube by continuous infusion should hang no longer than 4 to 6 hours before replacement of the milk, container, and tubing.245
For mothers who choose not to breast-feed, commercial infant formula is available. Most hospitals now use sterile, ready-to-feed formulas provided by the manufacturer in bottles, with sterile nipples to attach just before use. Nipples are best attached at the bedside just before feeding, and the unit should be used immediately and discarded within 4 hours after the bottle is uncapped.245
Specialty and less commonly used formulas may not be available as a ready-to-feed product, and breast milk supplements do not come in liquid form. After a recent report of a case of fatal Enterobacter sakazakii meningitis in a neonate fed contaminated powdered infant formula,97 concerns have risen about the safety of these products. Although powdered formulas are not sterile, preparation and storage practices can decrease the possibility of proliferation of microorganisms after preparation. The CDC, the Food and Drug Administration, and the American Dietetic Association offered updated recommendations on the safe preparation and administration of commercial formula after the recall of the product linked to the E. sakazakii case. These recommendations instruct the care provider as follows:
-
•
Use alternatives (ready-to-feed or concentrated formulas) to powdered infant formula whenever possible.
-
•
Prepare formula using aseptic technique in a designated formula preparation room.
-
•
Refrigerate prepared formula so that a temperature of 2° to 3°C is reached by 4 hours after preparation, and discard any reconstituted formula stored longer than 24 hours.
-
•
Limit ambient-temperature hang time of continuously infused formula to no longer than 4 hours.
-
•
Use hygienic handling techniques at feeding time, and avoid open delivery systems.
-
•
Have written guidelines for managing a manufacturer’s recall of contaminated formula.252
The FDA also recommended that boiling water be used to prepare powdered formulas, but concerns about this recommendation include potential damage to formula components from the high temperature of the water, a lack of evidence that using this method would kill potential pathogens in the formula, and risk of injury to persons preparing the formula.252
Co-bedding
The concept of co-bedding, or the bunking of twin infants (or other multiples) in a single isolette or crib, is being explored in NICUs for the potential benefits offered to the babies. Co-bedding as a component of developmentally supportive care is based on the premise that extrauterine adaptation of twin neonates is enhanced by continued physical contact with the other twin.253 Potential benefits need further study but may include increased bonding, decreased need for temperature support, and easier transition to home. It is certainly possible, however, for one of a set of multiples to be infected while the others are not, and for parents to be implicated as vectors in infection transmission. It also is possible for invasive devices and intravascular catheters to be dislodged by close contact with an active sibling. Therefore, exclusion criteria for co-bedding infants should include clinical findings suggesting infection that could be transmitted to a sibling (e.g., draining wound) and the need for drains and central venous or arterial lines.253, 254, 255
Visitors
The principles of family-centered care encourage liberal visitation policies, both in the well-baby nursery (or rooming-in scenario) and in the NICU. Parents, including fathers, should be allowed unlimited visitation to their newborns, and siblings also should be allowed liberal visitation. Expanding the number of visitors to neonates may, however, increase the risk of disease exposure if education and screening for symptoms of infection are not implemented. Written policies should be in place to guide sibling visits, and parents should be encouraged to share the responsibility of protecting their newborn from contagious illnesses. The Perinatal Guidelines regarding persons who visit newborns are listed in Table 35–10.
Table 35-10.
Guidelines for Sibling Visits to Well-Baby and High-Risk Nurseries
| Sibling visits should be encouraged for healthy and ill newborns. |
| Parents should be interviewed at a site outside the nursery to establish that the siblings are not ill before allowing them to visit. |
| Children with fever or other symptoms of an acute illness such as upper respiratory infection or gastroenteritis, or those recently exposed to a known communicable disease such as chickenpox, should not be allowed to visit. |
| Visiting children should visit only their sibling. |
| Children should be prepared in advance for their visit. |
| Visitors should be adequately observed and monitored by hospital staff. |
| Children should carefully wash their hands before patient contact. |
| Throughout the visit, siblings should be supervised by parents or another responsible adult. |
Data from American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Care of the neonate. In Gilstrap LC, Oh W (eds). Guidelines for Perinatal Care, 5th ed. Elk Grove Village, Ill, American Academy of Pediatrics, and Washington DC, American College of Obstetricians and Gynecologists, 2002, pp 331–353.
Adult visitors to neonates, including parents, have been implicated in outbreaks of infections including P. aeruginosa infection, pertussis, and Salmonella infection.132, 255, 256 Accordingly, the principles for sibling visitation should be applied to adult visitors as well. They should be screened for symptoms of contagious illness, instructed to perform hand hygiene before entering the NICU and before and after touching the neonate, and should interact only with the family member they came to the hospital to visit. Families of neonates who have lengthy NICU stays may come to know each other well and serve as sources of emotional support to one another. Nevertheless, they should be educated about the potential of transmitting microorganisms and infections between families if standard precautions and physical separation are not maintained, even though they may be sharing an inpatient space.
Skin and Cord Care
Bathing the newborn is standard practice in nurseries, but very little standardization in frequency or cleansing product exists. If not performed carefully, bathing actually can be detrimental to the infant, resulting in hypothermia, increased crying with resulting increases in oxygen consumption, respiratory distress, and instability of vital signs.257 Although the initial bath or cleansing should be delayed until the neonate’s temperature has been stable for several hours, removing blood and drying the skin immediately after delivery may remove potentially infectious microorganisms such as hepatitis B virus, HSV, and HIV, minimizing risk to the neonate from maternal infection.249 When the newborn requires an intramuscular injection in the delivery room, infection sites should be cleansed with alcohol to prevent transmission of organisms that may be present in maternal blood and body fluids.195 For routine bathing in the first few weeks of life, plain warm water should be used. This is especially important for preterm infants, as well as full-term infants with barrier compromise such as abrasions or dermatitis. If a soap is necessary for heavily soiled areas, a mild pH-neutral product without additives should be used, and duration of soaping should be restricted to less than 5 minutes no more than three times per week.257
Few randomized studies comparing cord care regimens and infection rates have been performed, and consensus has not been reached on best practice regarding care of the umbilical cord stump. A review published in 2003 described care regimens used for more than 2 decades, including combinations of triple dye, chlorhexidine, 70% alcohol, bacitracin, hexachlorophene, povidone-iodine, and “dry care” (soap and water cleansing of soiled periumbilical skin) and found variable impact on colonization of the stump.258 The study authors suggested that dry cord care alone may be insufficient and that chlorhexidine seemed to be a favorable antiseptic choice for cord care because of its activity against gram-positive and gram-negative bacteria. They went on to stress, however, that large, well-designed studies were required before firm conclusions could be drawn. The current Perinatal Guidelines do not recommend a specific regimen but warn that use of alcohol alone is not an effective method of preventing umbilical cord colonization and omphalitis.249 The Perinatal Guidelines further recommend that diapers be folded away from and below the stump and that emollients not be applied to the stump.257
Ocular Prophylaxis
Although blindness resulting from neonatal conjunctivitis is rare in the United States, with a reported incidence of 1.6% or less, the rate among the 80 million infants born annually throughout the world is as high as 23%.259 Chlamydia trachomatis has been the most common etiologic agent in the United States, but other organisms such as Neisseria gonorrhoeae, S. aureus, and E. coli also can cause ophthalmia neonatorum.260 Use of 1% silver nitrate drops, at one time the agent of choice, is no longer recommended because of concerns about associated chemical irritation. Agents thought to be equally efficacious and now recommended include 1% tetracycline and 0.5% erythromycin ophthalmic ointments, administered from sterile single-use tubes or vials.156, 245 Povidone-iodine (2.5%) ophthalmic solution also can be used and in one study was shown to be more effective than silver nitrate or erythromycin in the prevention of ophthalmia neonatorum. Bacterial resistance has not been seen with this agent, it causes less toxicity than either silver nitrate or erythromycin, and it is less expensive—a definite consideration in developing countries.259 Whatever the agent selected, it should reach all parts of the conjunctival sac, and the eyes should not be irrigated after application.
Ophthalmic agents will not necessarily prevent ocular or disseminated gonorrhea in infants born to mothers with active infection at time of delivery. These infants should be given parenteral antimicrobial therapy as well as ocular prophylaxis.195, 261 Some experts also advise giving infants born to mothers with untreated genital chlamydial infections a course of oral erythromycin beginning on the second or third day of life.261
Device-Related Infections
Primary Bloodstream Infections
Primary bloodstream infections (defined by the CDC NNIS System as being due to a pathogen cultured from one or more blood specimens not related to an infection at another site) account for a large proportion of infections in NICU infants,21 and most are related to the use of an intravascular catheter.36 Peripheral intravenous catheters (PIVs) are the most frequently used devices for the neonate for intravenous therapy of short duration. When longer access is necessary, nontunneled CVCs such as umbilical catheters and PICCs most commonly are used.195 The most recent data available from NNIS (August 2003) revealed that the mean umbilical catheter– and CVC-associated bloodstream infection rates for NICUs ranged from 10.6 per 1000 catheter days for infants whose birth weight was less than 1000 g to 3.7 per 1000 catheter days in infants whose birth weight was 2500g or more.194 The CDC recommends implementing strategies to reduce the incidence of such infections that strike a balance between patient safety and cost-effectiveness.
Few large studies of risks related to intravascular devices have been performed in NICU patients. As a result, intravascular device recommendations for neonates are based on those developed for adults and older pediatric patients (Table 35–11). Several differences in their management should be considered. Although the CDC recommends, in certain circumstances, using antimicrobial- or antiseptic-impregnated CVCs in adults whose catheters are expected to remain in place more than 5 days,36 these catheters are not available in sizes small enough for neonates. Of more importance, studies to evaluate their safety in neonates, especially premature neonates of very low birth weight, have not been performed. In addition, although the CDC recommends changing the insertion site of PIVs at least every 72 to 96 hours in adults, data suggest that leaving PIVs in place in pediatric patients does not increase the risk of complications.262 The 2002 CDC guidelines recommend that PIVs be left in place in children until therapy is completed, unless complications occur.
Table 35-11.
Strategies for Prevention of Catheter-Related Bloodstream Infections in Adult and Pediatric Patients
| Conduct surveillance in NICUs to determine catheter-related bloodstream infection rates, monitor trends, and identify infection control lapses. |
| Investigate events leading to unexpected life-threatening or fatal outcomes. |
| Select the catheter, insertion technique, and insertion site with the lowest risk for complications for the anticipated type and duration of intravenous therapy. |
| Use a CVC with the minimal number of ports essential for management of the patient. Designate one port for hyperalimentation if a multilumen catheter is used. |
| Educate HCWs who insert and maintain catheters, and assess their knowledge and competence periodically. |
| Use aseptic technique and maximal sterile barriers during insertion of CVCs (cap, mask, sterile gown, sterile gloves, and a large sterile barrier). |
| Do not routinely replace CVCs, PICCs, or pulmonary artery catheters to prevent catheter-related infections. Do not remove on the basis of fever alone. |
| In pediatric patients, leave peripheral venous catheters in place until intravenous therapy is completed unless a complication (e.g., phlebitis, infiltration) occurs. |
| Remove intravascular catheters promptly when no longer essential. |
| Observe proper hand hygiene procedures either by washing with antiseptic-containing soap and water or use of waterless alcohol-based products before and after working with intravascular lines. |
| Disinfect skin with an appropriate antiseptic before catheter insertion and during dressing changes. A 2% chlorhexidine-based preparation is preferred. |
| Do not use topical antibiotic ointment or creams on insertion sites, except when using dialysis catheters. |
| Use either sterile gauze or sterile, transparent, semipermeable dressing to cover the catheter site. Replace gauze dressings on short-term CVC sites every 2 days and transparent dressings at least weekly, except in pediatric patients, in whom the risk of dislodging the catheter outweighs the benefit of changing the dressing. Change if damp, loosened, or visibly soiled. |
| Replace dressings on tunneled or implanted CVC sites no more than once per week until the insertion site has healed. |
| Chlorhexidine sponge dressings are contraindicated in neonates younger than 7 days or those born at a gestational age of less than 26 weeks. |
| Clean injection ports with 70% alcohol or an iodophor before accessing the system. |
| Use disposable transducer assemblies with peripheral arterial catheters and pressure monitoring devices. Keep all components of such systems sterile, and do not administer dextrose-containing solutions or parenteral nutrition fluids through them. |
| CVC, central venous catheter; HCW, health care worker; NICU, neonatal intensive care unit; PICC, peripherally inserted central catheter. |
Data from Centers for Disease Control and Prevention. Guidelines for prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 51(No. RR-10):32, 2002.
Careful skin antisepsis before insertion of an intravascular catheter is critical to prevention of intravascular device– related bacteremia, although care in the selection of a product for use on neonatal skin is required. Chlorhexidine preparations are recommended by the CDC because these products have been found to be superior to povidone-iodine in reducing the risk for peripheral catheter colonization in neonates. Residues left on the skin by chlorhexidine prolong its half-life, providing improved protection for catheters in neonates that must be left in place for longer periods of time.257
Umbilical veins and arteries are available for CVC insertion only in neonates and are typically used for several days; thereafter, the CVC is replaced with another, nontunneled CVC or PICC if continued central venous access is required. The umbilicus provides a site that can be cannulated easily, allowing for collection of blood specimens and hemodynamic measurements, but after birth, the umbilicus quickly becomes heavily colonized with skin flora and other microorganisms. Colonization and catheter-related bloodstream infection rates for umbilical vein and umbilical artery catheters are similar. Colonization rates for umbilical artery catheters are estimated to be 40% to 55%; the estimated rate for umbilical artery catheter–related bloodstream infection is 5%.36 Colonization rates are from 22% to 59% for umbilical vein catheters; rates for umbilical vein catheter–related bloodstream infections are 3% to 8%.36 A summary of the CDC recommendations for management of umbilical catheters36 is presented in Table 35–12.
Table 35-12.
Summary of CDC Recommendations for Management of Umbilical Catheters
| Cleanse umbilical insertion site with an antiseptic before catheter insertion. Avoid tincture of iodine; povidone-iodine can be used. |
| Add low doses of heparin to fluid infused through umbilical artery catheters. |
| Remove and do not replace umbilical catheters if signs of catheter-related bloodstream infection, vascular insufficiency, or thrombosis are present. |
| Remove umbilical catheters as soon as possible when no longer needed or if any sign of vascular insufficiency to the lower extremities is observed. |
| Umbilical artery catheters should not be left in place for longer than 5 days. |
| Umbilical venous catheters should be removed as soon as possible when no longer needed but can be used for up to 14 days if managed aseptically. |
| CDC, Centers for Disease Control and Prevention. |
Data from Centers for Disease Control and Prevention. Guidelines for prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 51(No RR-10):32, 2002.
Ventilator-Associated Pneumonia
As mentioned earlier, NNIS data indicate that nosocomial pneumonia is the second most common infection type in NICU patients. Risk factors for ventilator-associated pneumonia can be grouped as host-related (prematurity, low birth weight, sedation or use of paralytic agents), device-related (endotracheal intubation, mechanical ventilation, orogastric or nasogastric tube placement) and factors that increase bacterial colonization of the stomach or nasopharynx (broad-spectrum antimicrobial agents, antacids, or H2 blockers).51, 264, 265 Ventilator-associated pneumonia generally refers to bacterial pneumonia that develops in patients who are receiving mechanical ventilation. Aspiration and direct inoculation of bacteria are the primary routes of entry into the lower respiratory tract; the source of these organisms may be the patient’s endogenous flora or transmission from other patients, staff members, or the environment.266, 267 Few studies have been performed to assess the effectiveness of prevention strategies in pediatric patients. Strategies to prevent ventilator-associated pneumonia in the NICU patient are therefore based primarily on studies performed in adults (Table 35–13). Hand hygiene remains critical to the prevention of ventilator-associated pneumonia, and HCWs should consistently apply the principles of standard precautions to the care of the ventilated patient, wearing gloves to handle respiratory secretions or objects contaminated by them, and changing gloves and performing hand hygiene between contacts with a contaminated body site and the respiratory tract or a respiratory tract device.
Table 35-13.
Effective Strategies for Prevention of Ventilator-Associated Pneumonia
| Removal of nasogastric or endotracheal tube as soon as clinically feasible |
| Adequate hand hygiene between patients |
| Semirecumbent positioning of the patient |
| Avoidance of unnecessary reintubation |
| Provision of adequate nutritional support |
| Avoidance of gastric overdistention |
| Scheduled drainage of condensate from ventilator circuits |
Data from Kollef MH. Current concepts: the prevention of ventilator-associated pneumonia. N Engl J Med 340:627–634, 1999.
Because mechanical ventilation is a significant risk factor for the development of nosocomial infection or ventilator-associated pneumonia, weaning from ventilation and removing endotracheal tubes as soon as indication for their use ceases are key infection control strategies. As an alternative to endotracheal intubation, noninvasive nasal continuous positive airway pressure (CPAP) ventilation avoids some of the common risk factors for ventilator-associated pneumonia and has been used successfully for neonates.268, 269 Respiratory care equipment that comes in contact with mucous membranes of ventilated patients or that is part of the ventilator circuit should be single use (discarded after one-time use with a single patient) or be subjected to sterilization or high-level disinfection between patients. Wet heat pasteurization (processing at 76°C for 30 minutes) or chemical disinfectants can be used to achieve high-level disinfection of reusable respiratory equipment.263 Ventilator circuits should be changed no more frequently than every 48 hours, and evidence suggests that extending the length of time between changes to 7 days does not increase the risk of ventilator-associated pneumonia.270, 271 Circuits should be monitored for accumulation of condensate and drained periodically, with care taken to avoid allowing the condensate, a potential reservoir for pathogens, to drain toward the patient.263, 267 Sterile fluids should be used for nebulization, and sterile water should be used to rinse reusable semicritical equipment and devices such as in-line medication nebulizers.263
Basic infection control measures, such as hand hygiene and wearing gloves during suctioning and respiratory manipulation, also can reduce the risk of nosocomial pneumonia. Both open, single-use and closed, multiuse suction systems are available. If an open system is used, a sterile single-use catheter should be used each time the patient is suctioned. Closed systems, which do not need to be changed daily and can be used for up to 7 days,272 have the advantage of lower costs and decreased environmental cross-contamination258 but have not been shown to decrease the incidence of nosocomial pneumonia when compared with open systems.273, 274
Although not well studied in pediatric patients, aspiration of oropharyngeal secretions is believed to contribute to development of ventilator-associated pneumonia in adults.275 Placing the mechanically ventilated patient in a semi-recumbent position or elevating the head of the bed in an attempt to minimize aspiration is recommended unless medically contraindicated. Also, placement of enteral feeding tubes should be verified before their use.263, 267 To prevent regurgitation and potential aspiration of stomach contents by the sedated patient, overdistention of the stomach should be avoided by regular monitoring of the patient’s intestinal motility, serial measurement of residual gastric volume or abdominal girth, reducing the use of narcotics and anticholinergic agents, and adjusting the rate and volume of enteral feedings.263, 267 Oral decontamination, with the intent of decreasing oropharyngeal colonization, has been studied in adults and seems to lower the incidence of ventilator-associated pneumonia (although not duration of ventilation or mortality rate),275, 276 but further work is needed to determine whether this is an effective strategy in neonates. In addition, medications such as sucralfate, as opposed to histamine H2 receptor antagonists and antacids, which raise gastric pH and can potentially result in increased bacterial colonization of the stomach, have been used to prevent development of stress ulcers and have been associated with lower incidence of ventilator-associated pneumonia in adults.277 Two studies suggest, however, that this approach is of no benefit in pediatric patients, but the authors stress that additional studies with larger sample sizes are needed to confirm these findings.278, 279
REFERENCES
- 1.Zafar N, Wallace CM, Kieffer P. Improving survival of vulnerable infants increases neonatal intensive care unit nosocomial infection rate. Arch Pediatr Adolesc Med. 2001;155:1098–1104. doi: 10.1001/archpedi.155.10.1098. [DOI] [PubMed] [Google Scholar]
- 2.Nagata E, Brito AS, Matsuo TL. Nosocomial infections in a neonatal intensive care unit: incidence and risk factors. Am J Infect Control. 2002;30:26–31. doi: 10.1067/mic.2002.119823. [DOI] [PubMed] [Google Scholar]
- 3.Bektas S, Goetze B, Speer CP. Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates. Acta Paediatr Scand. 1990;79:1031–1038. doi: 10.1111/j.1651-2227.1990.tb11379.x. [DOI] [PubMed] [Google Scholar]
- 4.Kallman J, Schollin J, Schalen C. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates. Arch Dis Child Fetal Neonatal Ed. 1998;78:F46–F50. doi: 10.1136/fn.78.1.f46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Madden NP, Levinsky RJ, Bayston R. Surgery, sepsis, and nonspecific immune function in neonates. J Pediatr Surg. 1989;24:562–566. doi: 10.1016/s0022-3468(89)80506-8. [DOI] [PubMed] [Google Scholar]
- 6.Stiehm ER. The physiologic immunodeficiency of immaturity. In: Stiehm ER, editor. Immunologic Disorders in Infants and Children. 4th ed. WB Saunders; Philadelphia: 1986. pp. 253–295. [Google Scholar]
- 7.Burchett SK, Corey L, Mohan KM. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis. 1992;165:813–818. doi: 10.1093/infdis/165.5.813. [DOI] [PubMed] [Google Scholar]
- 8.Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr. 1978;93:288–293. doi: 10.1016/s0022-3476(78)80523-x. [DOI] [PubMed] [Google Scholar]
- 9.Sprunt K. Practical use of surveillance for prevention of nosocomial infection. Semin Perinatol. 1985;9:47–50. [PubMed] [Google Scholar]
- 10.Bennet R, Eriksson M, Nord CE, Zetterstrom R. Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis. 1986;5:533–539. doi: 10.1097/00006454-198609000-00009. [DOI] [PubMed] [Google Scholar]
- 11.Hall SL, Riddell SW, Barnes WG. Evaluation of coagulase-negative staphylococcal isolates from serial nasopharyngeal cultures of premature infants. Diagn Microbiol Infect Dis. 1990;13:17–23. doi: 10.1016/0732-8893(90)90048-z. [DOI] [PubMed] [Google Scholar]
- 12.Fryklund B, Tullus K, Berglund B, Burman LG. Importance of the environment and the faecal flora of infants, nursing staff and parents as sources of gram-negative bacteria colonizing newborns in three neonatal wards. Infection. 1992;20:253–257. doi: 10.1007/BF01710789. [DOI] [PubMed] [Google Scholar]
- 13.Pessoa-Silva CL, Meurer Moreira B, Camara Almeida V. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J Hosp Infect. 2003;53:198–206. doi: 10.1053/jhin.2002.1373. [DOI] [PubMed] [Google Scholar]
- 14.Saiman L, Ludington E, Dawson JD. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20:1119–1124. doi: 10.1097/00006454-200112000-00005. [DOI] [PubMed] [Google Scholar]
- 15.Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol. 1996;17:47–52. doi: 10.1086/647189. [DOI] [PubMed] [Google Scholar]
- 16.el-Mohandes AE, Picard MB, Simmens SJ, Keiser JF. Use of human milk in the intensive care nursery decreases the incidence of nosocomial sepsis. J Perinatol. 1997;17:130–134. [PubMed] [Google Scholar]
- 17.Shattuck KE, Cochran CK, Zabransky RJ. Colonization and infection associated with Malassezia and Candida species in a neonatal unit. J Hosp Infect. 1996;34:123–129. doi: 10.1016/s0195-6701(96)90137-1. [DOI] [PubMed] [Google Scholar]
- 18.Pittet D, Dharan S, Touveneau S. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med. 1999;159:821–826. doi: 10.1001/archinte.159.8.821. [DOI] [PubMed] [Google Scholar]
- 19.Baltimore RS. Neonatal nosocomial infections. Semin Perinatol. 1998;22:25–32. doi: 10.1016/s0146-0005(98)80005-0. [DOI] [PubMed] [Google Scholar]
- 20.Gaynes RP, Edwards JR, Jarvis WR. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics. 1996;98:357–361. [PubMed] [Google Scholar]
- 21.Sohn AH, Garrett DO, Sinkowitz-Cochran RL. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr. 2001;139:821–827. doi: 10.1067/mpd.2001.119442. [DOI] [PubMed] [Google Scholar]
- 22.Scheckler WE, Brimhall D, Buck AS. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Health Care Epidemiology of America. Am J Infect Control. 1998;26:47–60. doi: 10.1016/s0196-6553(98)70061-6. [DOI] [PubMed] [Google Scholar]
- 23.Neumann PW, O’Shaughnessy M, Garnett M. Laboratory evidence of human immunodeficiency virus infection in Canada in 1986. Can Med Assoc J. 1987;137:823. [PMC free article] [PubMed] [Google Scholar]
- 24.Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control, Health and Welfare, Canada Canadian nosocomial infection surveillance program: annual summary, June 1984–May 1985. Can Dis Wkly Rep. 1986;12:S1. [Google Scholar]
- 25.Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:53–80. doi: 10.1086/647190. [DOI] [PubMed] [Google Scholar]
- 26.Larson EL, Bryan JL, Adler LM, Blane C. A multifaceted approach to changing handwashing behavior. Am J Infect Control. 1997;25:3–10. doi: 10.1016/s0196-6553(97)90046-8. [DOI] [PubMed] [Google Scholar]
- 27.Pittet D, Hugonnet S, Harbarth S. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 2000;356:1307–1312. doi: 10.1016/s0140-6736(00)02814-2. [DOI] [PubMed] [Google Scholar]
- 28.Larson E. Skin hygiene and infection prevention: more of the same or different approaches? Clin Infect Dis. 1999;29:1287–1294. doi: 10.1086/313468. [DOI] [PubMed] [Google Scholar]
- 29.Villari P, Sarnataro C, Iacuzio L. Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J Clin Microbiol. 2000;38:1740–1746. doi: 10.1128/jcm.38.5.1740-1746.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Carlos CC, Ringertz S, Rylander M. Nosocomial Staphylococcus epidermidis septicaemia among very low birth weight neonates in an intensive care unit. J Hosp Infect. 1991;19:201–207. doi: 10.1016/0195-6701(91)90224-v. [DOI] [PubMed] [Google Scholar]
- 31.Beck-Sague CM, Azimi P, Fonseca SN. Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J. 1994;13:1110–1116. [PubMed] [Google Scholar]
- 32.Chien LY, MacNab Y, Aziz K. Variations in central venous catheter-related infection risks among Canadian neonatal intensive care units. Pediatr Infect Dis J. 2002;21:505–511. doi: 10.1097/00006454-200206000-00006. [DOI] [PubMed] [Google Scholar]
- 33.Cronin WA, Germanson TP, Donowitz LG. Intravascular catheter colonization and related bloodstream infection in critically ill neonates. Infect Control Hosp Epidemiol. 1990;11:301–308. doi: 10.1086/646175. [DOI] [PubMed] [Google Scholar]
- 34.Mahieu LM, De Muynck AO, Ieven MM. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect. 2001;48:108–116. doi: 10.1053/jhin.2001.0984. [DOI] [PubMed] [Google Scholar]
- 35.Matlow AG, Kitai I, Kirpalani H. A randomized trial of 72-versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol. 1999;20:487–493. doi: 10.1086/501657. [DOI] [PubMed] [Google Scholar]
- 36.O’Grady NP, Alexander M, Dellinger EP. Guidelines for the prevention of intravascular catheter–related infections. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 2002;51(No. RR-10):1–26. [PubMed] [Google Scholar]
- 37.Shulman RJ, Pokorny WJ, Martin CG. Comparison of percutaneous and surgical placement of central venous catheters in neonates. J Pediatr Surg. 1986;21:348–350. doi: 10.1016/s0022-3468(86)80201-9. [DOI] [PubMed] [Google Scholar]
- 38.Brodie SB, Sands KE, Gray JE. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J. 2000;19:56–65. doi: 10.1097/00006454-200001000-00012. [DOI] [PubMed] [Google Scholar]
- 39.Sirota L, Straussberg R, Notti I, Bessler H. Effect of lipid emulsion on IL-2 production by mononuclear cells of newborn infants and adults. Acta Paediatr. 1997;86:410–413. doi: 10.1111/j.1651-2227.1997.tb09032.x. [DOI] [PubMed] [Google Scholar]
- 40.Moro ML, De Toni A, Stolfi I. Risk factors for nosocomial sepsis in newborn intensive and intermediate care units. Eur J Pediatr. 1996;155:315–322. doi: 10.1007/BF02002720. [DOI] [PubMed] [Google Scholar]
- 41.Sirot D. Extended-spectrum plasmid-mediated beta-lactamases. J Antimicrob Chemother. 1995;36(Suppl A):19–34. doi: 10.1093/jac/36.suppl_a.19. [DOI] [PubMed] [Google Scholar]
- 42.Saiman L, Ludington E, Pfaller M. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000;19:319–324. doi: 10.1097/00006454-200004000-00011. [DOI] [PubMed] [Google Scholar]
- 43.Stoll BJ, Temprosa M, Tyson JE. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics. 1999;104:e63. doi: 10.1542/peds.104.5.e63. [DOI] [PubMed] [Google Scholar]
- 44.Papile LA, Tyson JE, Stoll BJ. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 1998;16:1112–1118. doi: 10.1056/NEJM199804163381604. [DOI] [PubMed] [Google Scholar]
- 45.Richardson DK, Gray JE, McCormick MC. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics. 1993;91:617–623. [PubMed] [Google Scholar]
- 46.The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units The International Neonatal Network. Lancet. 1993;342:193–198. [PubMed] [Google Scholar]
- 47.Tucker J. Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation. Lancet. 2002;359:99–107. doi: 10.1016/s0140-6736(02)07366-x. [DOI] [PubMed] [Google Scholar]
- 48.Goldmann DA, Durbin WA, Jr, Freeman J. Nosocomial infections in a neonatal intensive care unit. J Infect Dis. 1981;144:449–459. doi: 10.1093/infdis/144.5.449. [DOI] [PubMed] [Google Scholar]
- 49.Makhoul IR, Sujov P, Smolkin T. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics. 2002;109:34–39. doi: 10.1542/peds.109.1.34. [DOI] [PubMed] [Google Scholar]
- 50.Karlowicz MG, Giannone PJ, Pestian J. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (≤1000 g) neonates? Pediatrics. 2000;105:1036–1040. doi: 10.1542/peds.105.5.1036. [DOI] [PubMed] [Google Scholar]
- 51.Petdachai W. Nosocomial pneumonia in a newborn intensive care unit. J Med Assoc Thai. 2000;83:392–397. [PubMed] [Google Scholar]
- 52.Cordero L, Ayers LW, Miller RR. Surveillance of ventilator-associated pneumonia in very-low-birth-weight infants. Am J Infect Control. 2002;30:32–39. doi: 10.1067/mic.2002.119995. [DOI] [PubMed] [Google Scholar]
- 53.Iroha EO, Kesah CN, Egri-Okwaji MT, Odugbemi TO. Bacterial eye infection in neonates, a prospective study in a neonatal unit. West Afr J Med. 1998;17:168–172. [PubMed] [Google Scholar]
- 54.Boccia D, Stolfi I, Lana S, Moro ML. Nosocomial necrotising enterocolitis outbreaks: epidemiology and control measures. Eur J Pediatr. 2001;160:385–391. doi: 10.1007/s004310100749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Rotbart HA, Levin MJ. How contagious is necrotizing enterocolitis? Pediatr Infect Dis. 1983;2:406–413. doi: 10.1097/00006454-198309000-00019. [DOI] [PubMed] [Google Scholar]
- 56.Nakano M, Miyazawa H, Kawano Y. An outbreak of neonatal toxic shock syndrome–like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit. Microbiol Immunol. 2002;46:277–284. doi: 10.1111/j.1348-0421.2002.tb02696.x. [DOI] [PubMed] [Google Scholar]
- 57.Andersen BM, Lindemann R, Bergh K. Spread of methicillin-resistant Staphylococcus aureus in a neonatal intensive unit associated with understaffing, overcrowding and mixing of patients. J Hosp Infect. 2002;50:18–24. doi: 10.1053/jhin.2001.1128. [DOI] [PubMed] [Google Scholar]
- 58.Saito Y, Seki K, Ohara T. Epidemiologic typing of methicillin-resistant Staphylococcus aureus in neonate intensive care units using pulsed-field gel electrophoresis. Microbiol Immunol. 1998;42:723–729. doi: 10.1111/j.1348-0421.1998.tb02345.x. [DOI] [PubMed] [Google Scholar]
- 59.Belani A, Sherertz RJ, Sullivan ML. Outbreak of staphylococcal infection in two hospital nurseries traced to a single nasal carrier. Infect Control. 1986;7:487–490. doi: 10.1017/s0195941700065097. [DOI] [PubMed] [Google Scholar]
- 60.Ish-Horowicz MR, McIntyre P, Nade S. Bone and joint infections caused by multiply resistant Staphylococcus aureus in a neonatal intensive care unit. Pediatr Infect Dis J. 1992;11:82–87. doi: 10.1097/00006454-199202000-00005. [DOI] [PubMed] [Google Scholar]
- 61.Sabatino G, Verrotti A, de Martino M. Neonatal suppurative parotitis: a study of five cases. Eur J Pediatr. 1999;158:312–314. doi: 10.1007/s004310051079. [DOI] [PubMed] [Google Scholar]
- 62.Saiman L, Jakob K, Holmes KW. Molecular epidemiology of staphylococcal scalded skin syndrome in premature infants. Pediatr Infect Dis J. 1998;17:329–334. doi: 10.1097/00006454-199804000-00012. [DOI] [PubMed] [Google Scholar]
- 63.Dave J, Reith S, Nash JQ. A double outbreak of exfoliative toxin-producing strains of Staphylococcus aureus in a maternity unit. Epidemiol Infect. 1994;112:103–114. doi: 10.1017/s0950268800057460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Wolinsky E, Lipsitz PJ, Mortimer EA, Jr, Rammelkamp CH., Jr Acquisition of staphylococci by newborns. Direct versus indirect transmission. Lancet. 1960;2:620–622. doi: 10.1016/s0140-6736(60)91693-7. [DOI] [PubMed] [Google Scholar]
- 65.Mortimer EA, Jr, Lipsitz PJ, Wolinsky E. Transmission of staphylococci between newborns. Importance of the hands to personnel. Am J Dis Child. 1962;104:289–295. doi: 10.1001/archpedi.1962.02080030291012. [DOI] [PubMed] [Google Scholar]
- 66.Haley RW, Bregman DA. The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit. J Infect Dis. 1982;145:875–885. doi: 10.1093/infdis/145.6.875. [DOI] [PubMed] [Google Scholar]
- 67.Eichenwald HF, Kotsevalov O, Fasso LA. The “cloud baby”: an example of bacterial-viral interaction. Am J Dis Child. 1960;100:161–173. doi: 10.1001/archpedi.1960.04020040163003. [DOI] [PubMed] [Google Scholar]
- 68.Sheretz RJ, Reagan DR, Hampton KD. A cloud adult: the Staphylococcus aureus–virus interaction revisited. Ann Intern Med. 1996;124:539–547. doi: 10.7326/0003-4819-124-6-199603150-00001. [DOI] [PubMed] [Google Scholar]
- 69.Morel AS, Wu F, Della-Latta P. Nosocomial transmission of methicillin-resistant Staphylococcus aureus from a mother to her preterm quadruplet infants. Am J Infect Control. 2002;30:170–173. doi: 10.1067/mic.2002.119819. [DOI] [PubMed] [Google Scholar]
- 70.Hitomi S, Kubota M, Mori N. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect. 2000;46:123–129. doi: 10.1053/jhin.2000.0786. [DOI] [PubMed] [Google Scholar]
- 71.Hayakawa T, Hayashidera T, Yoneda K. Preferential pharyngeal colonization of methicillin resistant Staphylococcus aureus in infants. J Pediatr. 1999;134:252. doi: 10.1016/s0022-3476(99)70435-x. [DOI] [PubMed] [Google Scholar]
- 72.Hayakawa T, Hayashidera T, Katsura S. Nasal mupirocin treatment of pharynx-colonized methicillin resistant Staphylococcus aureus: preliminary study with 10 carrier infants. Pediatr Int. 2000;42:67–70. doi: 10.1046/j.1442-200x.2000.01177.x. [DOI] [PubMed] [Google Scholar]
- 73.Isaacs D. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed. 2003;88:F89–F93. doi: 10.1136/fn.88.2.F89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics. 1995;95:225–230. [PubMed] [Google Scholar]
- 75.Sharek PJ, Benitz WE, Abel NJ. Effect of an evidence-based hand washing policy on hand washing rates and false-positive coagulase negative staphylococcus blood and cerebrospinal fluid culture rates in a level III NICU. J Perinatol. 2002;22:137–143. doi: 10.1038/sj.jp.7210661. [DOI] [PubMed] [Google Scholar]
- 76.Coudron PE, Mayhall CG, Facklam RR. Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol. 1984;20:1044–1048. doi: 10.1128/jcm.20.6.1044-1048.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Luginbuhl LM, Rotbart HA, Facklam RR. Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J. 1987;6:1022–1026. [PubMed] [Google Scholar]
- 78.McNeeley DF, Saint-Louis F, Noel GJ. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. Pediatr Infect Dis J. 1996;15:800–805. doi: 10.1097/00006454-199609000-00013. [DOI] [PubMed] [Google Scholar]
- 79.Rupp ME, Marion N, Fey PD. Outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2001;22:301–303. doi: 10.1086/501905. [DOI] [PubMed] [Google Scholar]
- 80.Centers for Disease Control and Prevention Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) MMWR Morb Mortal Wkly Rep. 1995;44(No. RR-12):1–13. [PubMed] [Google Scholar]
- 81.Geil CC, Castle WK, Mortimer EA., Jr Group A streptococcal infections in newborn nurseries. Pediatrics. 1970;46:849–854. [PubMed] [Google Scholar]
- 82.Campbell JR, Arango CA, Garcia-Prats JA. An outbreak of M serotype 1 group A Streptococcus in a neonatal intensive care unit. J Pediatr. 1996;129:396–402. [PubMed] [Google Scholar]
- 83.Bingen E, Denamur E, Lambert-Zechovsky N. Mother-to-infant vertical transmission and cross-colonization of Streptococcus pyogenes confirmed by DNA restriction fragment length polymorphism analysis. J Infect Dis. 1992;165:147–150. doi: 10.1093/infdis/165.1.147. [DOI] [PubMed] [Google Scholar]
- 84.Isenberg HD, Tucci V, Lipsitz P, Facklam RR. Clinical laboratory and epidemiological investigations of a Streptococcus pyogenes cluster epidemic in a newborn nursery. J Clin Microbiol. 1984;19:366–370. doi: 10.1128/jcm.19.3.366-370.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Brunton WA. Infection and hospital laundry. Lancet. 1995;345:1574–1575. doi: 10.1016/s0140-6736(95)91124-3. [DOI] [PubMed] [Google Scholar]
- 86.Paredes A, Wong P, Mason EO., Jr Nosocomial transmission of group B streptococci in a newborn nursery. Pediatrics. 1977;59:679–682. [PubMed] [Google Scholar]
- 87.Aber RC, Allen N, Howell JT. Nosocomial transmission of group B streptococci. Pediatrics. 1976;58:346–353. [PubMed] [Google Scholar]
- 88.Anthony BF, Okada DM, Hobel CJ. Epidemiology of the group B Streptococcus: maternal and nosocomial sources for infant acquisitions. J Pediatr. 1979;95:431–436. doi: 10.1016/s0022-3476(79)80530-2. [DOI] [PubMed] [Google Scholar]
- 89.Easmon CS, Hastings MJ, Clare AJ. Nosocomial transmission of group B streptococci. Br Med J. 1981;283:459–461. doi: 10.1136/bmj.283.6289.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Noya FJ, Rench MA, Metzger TG. Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis. 1987;155:1135–1144. doi: 10.1093/infdis/155.6.1135. [DOI] [PubMed] [Google Scholar]
- 91.Lin FY, Weisman LE, Troendle J, Adams K. Prematurity is the major risk factor for late-onset group B streptococcus disease. J Infect Dis. 2003;188:267–271. doi: 10.1086/376457. [DOI] [PubMed] [Google Scholar]
- 92.Olver WJ, Bond DW, Boswell TC, Watkin SL. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed. 2000;83:F48–F49. doi: 10.1136/fn.83.1.F48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Ayan M, Kuzucu C, Durmaz R. Analysis of three outbreaks due to Klebsiella species in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003;24:495–500. doi: 10.1086/502245. [DOI] [PubMed] [Google Scholar]
- 94.van den Berg RW, Claahsen HL, Niessen M. Enterobacter cloacae outbreak in the NICU related to disinfected thermometers. J Hosp Infect. 2000;45:29–34. doi: 10.1053/jhin.1999.0657. [DOI] [PubMed] [Google Scholar]
- 95.Archibald LK, Ramos M, Arduino MJ. Enterobacter cloacae and Pseudomonas aeruginosa polymicrobial bloodstream infections traced to extrinsic contamination of a dextrose multidose vial. J Pediatr. 1998;133:640–644. doi: 10.1016/s0022-3476(98)70104-0. [DOI] [PubMed] [Google Scholar]
- 96.Matsaniotis NS, Syriopoulou VP, Theodoridou MC. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infect Control. 1984;5:471–477. doi: 10.1017/s0195941700060872. [DOI] [PubMed] [Google Scholar]
- 97.Centers for Disease Control and Prevention Enterobacter sakazakii infections associated with the use of powdered infant formula—Tennessee, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:298–300. [PubMed] [Google Scholar]
- 98.Harbarth S, Sudre P, Dharan S. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol. 1999;20:598–603. doi: 10.1086/501677. [DOI] [PubMed] [Google Scholar]
- 99.Yu WL, Cheng HS, Lin HC. Outbreak investigation of nosocomial Enterobacter cloacae bacteraemia in a neonatal intensive care unit. Scand J Infect Dis. 2000;32:293–298. doi: 10.1080/00365540050165947. [DOI] [PubMed] [Google Scholar]
- 100.Donowitz LG, Marsik FJ, Fisher KA, Wenzel RP. Contaminated breast milk: A source of Klebsiella bacteremia in a newborn intensive care unit. Rev Infect Dis. 1981;3:716–720. doi: 10.1093/clinids/3.4.716. [DOI] [PubMed] [Google Scholar]
- 101.Al-Rabea AA, Burwen DR, Eldeen MA. Klebsiella pneumoniae bloodstream infections in neonates in a hospital in the Kingdom of Saudi Arabia. Infect Control Hosp Epidemiol. 1998;19:674–679. doi: 10.1086/647897. [DOI] [PubMed] [Google Scholar]
- 102.Lalitha MK, Kenneth J, Jana AK. Identification of an IV-dextrose solution as the source of an outbreak of Klebsiella pneumoniae sepsis in a newborn nursery. J Hosp Infect. 1999;43:70–73. doi: 10.1053/jhin.1999.0619. [DOI] [PubMed] [Google Scholar]
- 103.Cotton MF, Wasserman E, Pieper CH. Invasive disease due to extended spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: the possible role of cockroaches. J Hosp Infect. 2000;44:13–17. doi: 10.1053/jhin.1999.0650. [DOI] [PubMed] [Google Scholar]
- 104.Reiss I, Borkhardt A, Fussle R. Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies. Lancet. 2000;356:310. doi: 10.1016/S0140-6736(00)02509-5. [DOI] [PubMed] [Google Scholar]
- 105.Jeong SH, Kim WM, Chang CL. Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase. J Hosp Infect. 2001;48:281–288. doi: 10.1053/jhin.2001.1018. [DOI] [PubMed] [Google Scholar]
- 106.Macrae MB, Shannon KP, Rayner DM. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J Hosp Infect. 2001;49:183–192. doi: 10.1053/jhin.2001.1066. [DOI] [PubMed] [Google Scholar]
- 107.Gaillot O, Maruejouls C, Abachin E. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol. 1998;36:1357–1360. doi: 10.1128/jcm.36.5.1357-1360.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Tullus K, Horlin K, Svenson SB, Kallenius G. Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of P fimbriated Escherichia coli in children. J Infect Dis. 1984;150:728–736. doi: 10.1093/infdis/150.5.728. [DOI] [PubMed] [Google Scholar]
- 109.Adhikari M, Coovadia Y, Hewitt J. Enteropathogenic Escherichia coli (EPEC) and enterotoxigenic (ETEC) related diarrhoeal disease in a neonatal unit. Ann Trop Paediatr. 1985;5:19–22. doi: 10.1080/02724936.1985.11748353. [DOI] [PubMed] [Google Scholar]
- 110.Gerards LJ, Hennekam RC, von Dijk WC. An outbreak of gastroenteritis due to Escherichia coli 0142 H6 in a neonatal department. J Hosp Infect. 1984;5:283–288. doi: 10.1016/0195-6701(84)90077-x. [DOI] [PubMed] [Google Scholar]
- 111.Villari P, Crispino M, Salvadori A, Scarcella A. Molecular epidemiology of an outbreak of Serratia marcescens in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2001;22:630–634. doi: 10.1086/501834. [DOI] [PubMed] [Google Scholar]
- 112.Assadian O, Berger A, Aspock C. Nosocomial outbreak of Serratia marcescens in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2002;23:457–461. doi: 10.1086/502085. [DOI] [PubMed] [Google Scholar]
- 113.van Ogtrop ML, van Zoeren-Grobben D, Verbakel-Salomons EM, van Boven CP. Serratia marcescens infections in neonatal departments: description of an outbreak and review of the literature. J Hosp Infect. 1997;36:95–103. doi: 10.1016/s0195-6701(97)90115-8. [DOI] [PubMed] [Google Scholar]
- 114.Archibald LK, Corl A, Shah B. Serratia marcescens outbreak associated with extrinsic contamination of 1% chlorxylenol soap. Infect Control Hosp Epidemiol. 1997;18:704–709. doi: 10.1086/647516. [DOI] [PubMed] [Google Scholar]
- 115.Fleisch F, Zimmermann-Baer U, Zbinden R. Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis. 2002;34:767–773. doi: 10.1086/339046. [DOI] [PubMed] [Google Scholar]
- 116.Berthelot P, Grattard F, Amerger C. Investigation of a nosocomial outbreak due to Serratia marcescens in a maternity hospital. Infect Control Hosp Epidemiol. 1999;20:233–236. doi: 10.1086/501617. [DOI] [PubMed] [Google Scholar]
- 117.Gransden WR, Webster M, French GL, Phillips I. An outbreak of Serratia marcescens transmitted by contaminated breast pumps in a special care baby unit. J Hosp Infect. 1986;7:149–154. doi: 10.1016/0195-6701(86)90057-5. [DOI] [PubMed] [Google Scholar]
- 118.Moloney AC, Quoraishi AH, Parry P, Hall V. A bacteriological examination of breast pumps. J Hosp Infect. 1987;9:169–174. doi: 10.1016/0195-6701(87)90056-9. [DOI] [PubMed] [Google Scholar]
- 119.Jang TN, Fung CP, Yang TL. Use of pulsed-field gel electrophoresis to investigate an outbreak of Serratia marcescens infection in a neonatal intensive care unit. J Hosp Infect. 2001;48:13–19. doi: 10.1053/jhin.2001.0947. [DOI] [PubMed] [Google Scholar]
- 120.Venezia RA, Scarano FJ, Preston KE. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis. 1995;21:915–923. doi: 10.1093/clinids/21.4.915. [DOI] [PubMed] [Google Scholar]
- 121.Shannon K, Fung K, Stapleton P. A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance. J Hosp Infect. 1998;39:291–300. doi: 10.1016/s0195-6701(98)90294-8. [DOI] [PubMed] [Google Scholar]
- 122.Martinez-Aguilar G, Alpuche-Aranda CM, Anaya C. Outbreak of nosocomial sepsis and pneumonia in a newborn intensive care unit by multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: high impact on mortality. Infect Control Hosp Epidemiol. 2001;22:725–728. doi: 10.1086/501855. [DOI] [PubMed] [Google Scholar]
- 123.Leigh L, Stoll BJ, Rahman M, McGowan J., Jr Pseudomonas aeruginosa infection in very low birth weight infants: a case-control study. Pediatr Infect Dis J. 1995;14:367–371. doi: 10.1097/00006454-199505000-00006. [DOI] [PubMed] [Google Scholar]
- 124.Becks VE, Lorenzoni NM. Pseudomonas aeruginosa outbreak in a neonatal intensive care unit: a possible link to contaminated hand lotion. Am J Infect Control. 1995;23:396–398. doi: 10.1016/0196-6553(95)90272-4. [DOI] [PubMed] [Google Scholar]
- 125.McNeil MM, Solomon SL, Anderson RL. Nosocomial Pseudomonas pickettii colonization associated with a contaminated respiratory therapy solution in a special care nursery. J Clin Microbiol. 1985;22:903–907. doi: 10.1128/jcm.22.6.903-907.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Muyldermans G, de Smet F, Pierard D. Neonatal infections with Pseudomonas aeruginosa associated with a water-bath used to thaw fresh frozen plasma. J Hosp Infect. 1998;39:309–314. doi: 10.1016/s0195-6701(98)90296-1. [DOI] [PubMed] [Google Scholar]
- 127.Garland SM, Mackay S, Tabrizi S, Jacobs S. Pseudomonas aeruginosa outbreak associated with a contaminated blood-gas analyser in a neonatal intensive care unit. J Hosp Infect. 1996;33:145–151. doi: 10.1016/s0195-6701(96)90099-7. [DOI] [PubMed] [Google Scholar]
- 128.Vochem M, Vogt M, Doring G. Sepsis in a newborn due to Pseudomonas aeruginosa from a contaminated tub bath. N Engl J Med. 2001;345:378–379. doi: 10.1056/NEJM200108023450517. [DOI] [PubMed] [Google Scholar]
- 129.Foca M, Jakob K, Whittier S. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med. 2000;343:695–700. doi: 10.1056/NEJM200009073431004. [DOI] [PubMed] [Google Scholar]
- 130.Moolenaar RL, Crutcher JM, San Joaquin VH. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol. 2000;21:80–85. doi: 10.1086/501739. [DOI] [PubMed] [Google Scholar]
- 131.Boyce JM, Pittet D. Guideline for hand hygiene in healthcare settings. Recommendations of the Health Care Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Health Care Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51:1–45. [PubMed] [Google Scholar]
- 132.Spearing NM, Horvath RL, McCormack JG. Pertussis: adults as a source in health care settings. Med J Aust. 2002;177:568–569. doi: 10.5694/j.1326-5377.2002.tb04956.x. [DOI] [PubMed] [Google Scholar]
- 133.Centers for Disease Control and Prevention Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin— Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep. 1999;48:1117–1120. [PubMed] [Google Scholar]
- 134.Honein MA, Paulozzi LJ, Himelright IM. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. Lancet. 1999;354:2101–2105. doi: 10.1016/s0140-6736(99)10073-4. [DOI] [PubMed] [Google Scholar]
- 135.American Academy of Pediatrics . Pertussis. In: Pickering LK, editor. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. American Academy of Pediatrics; Elk Grove Village, Ill: 2003. pp. 472–486. [Google Scholar]
- 136.Nivin B, Nicholas P, Gayer M. A continuing outbreak of multidrug-resistant tuberculosis, with transmission in a hospital nursery. Clin Infect Dis. 1998;26:303–307. doi: 10.1086/516296. [DOI] [PubMed] [Google Scholar]
- 137.Burk JR, Bahar D, Wolf FS. Nursery exposure of 528 newborns to a nurse with pulmonary tuberculosis. South Med J. 1978;71:7–10. doi: 10.1097/00007611-197801000-00004. [DOI] [PubMed] [Google Scholar]
- 138.Centers for Disease Control and Prevention Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. MMWR Morb Mortal Wkly Rep. 1994;43(No. RR-13):1–132. [PubMed] [Google Scholar]
- 139.Phillips JR, Karlowicz MG. Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr Infect Dis J. 1997;16:190–194. doi: 10.1097/00006454-199702000-00005. [DOI] [PubMed] [Google Scholar]
- 140.Huang YC, Li CC, Lin TY. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J. 1998;17:819–822. doi: 10.1097/00006454-199809000-00014. [DOI] [PubMed] [Google Scholar]
- 141.Roilides E, Farmaki E, Evdoridou J. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol. 2003;41:735–741. doi: 10.1128/JCM.41.2.735-741.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Gagneur A, Sizun J, Vernotte E. Low rate of Candida parapsilosis– related colonization and infection in hospitalized preterm infants: a one-year prospective study. J Hosp Infect. 2001;48:193–197. doi: 10.1053/jhin.2001.1007. [DOI] [PubMed] [Google Scholar]
- 143.Benjamin DK, Jr, Ross K, McKinney RE., Jr When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics. 2000;106:712–718. doi: 10.1542/peds.106.4.712. [DOI] [PubMed] [Google Scholar]
- 144.Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit. Diagn Microbiol Infect Dis. 1995;21:191–194. doi: 10.1016/0732-8893(95)00048-f. [DOI] [PubMed] [Google Scholar]
- 145.Waggoner-Fountain LA, Walker MW, Hollis RJ. Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis. 1996;22:803–808. doi: 10.1093/clinids/22.5.803. [DOI] [PubMed] [Google Scholar]
- 146.Huang YC, Lin TY, Peng HL. Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis. 1998;30:137–142. doi: 10.1080/003655498750003519. [DOI] [PubMed] [Google Scholar]
- 147.Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr. 2001;90:323–327. [PubMed] [Google Scholar]
- 148.Chang HJ, Miller HL, Watkins N. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers’ pet dogs. N Engl J Med. 1998;338:706–711. doi: 10.1056/NEJM199803123381102. [DOI] [PubMed] [Google Scholar]
- 149.Aragao PA, Oshiro IC, Manrique EI. Pichia anomala outbreak in a nursery: exogenous source? Pediatr Infect Dis J. 2001;20:843–848. doi: 10.1097/00006454-200109000-00004. [DOI] [PubMed] [Google Scholar]
- 150.Chakrabarti A, Singh K, Narang A. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol. 2001;39:1702–1706. doi: 10.1128/JCM.39.5.1702-1706.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Groll AH, Jaeger G, Allendorf A. Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis. 1998;27:437–452. doi: 10.1086/514717. [DOI] [PubMed] [Google Scholar]
- 152.Singer S, Singer D, Ruchel R. Outbreak of systemic aspergillosis in a neonatal intensive care unit. Mycoses. 1998;41:223–227. doi: 10.1111/j.1439-0507.1998.tb00328.x. [DOI] [PubMed] [Google Scholar]
- 153.Mitchell SJ, Gray J, Morgan ME. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet. 1996;348:441–443. doi: 10.1016/s0140-6736(96)05059-3. [DOI] [PubMed] [Google Scholar]
- 154.Drusin LM, Ross BG, Rhodes KH. Nosocomial ringworm in a neonatal intensive care unit: a nurse and her cat. Infect Control Hosp Epidemiol. 2000;21:605–607. doi: 10.1086/501814. [DOI] [PubMed] [Google Scholar]
- 155.Sharma R, Hudak ML, Premachandra BR. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J. 2002;21:1099–1105. doi: 10.1097/00006454-200212000-00003. [DOI] [PubMed] [Google Scholar]
- 156.Sattar SA, Jacobsen H, Rahman H. Interruption of rotavirus spread through chemical disinfection. Infect Control Hosp Epidemiol. 1994;15:751–756. doi: 10.1086/646852. [DOI] [PubMed] [Google Scholar]
- 157.Widdowson MA, van Doornum GJ, van der Poel WH. An outbreak of diarrhea in a neonatal medium care unit caused by a novel strain of rotavirus: investigation using both epidemiologic and microbiological methods. Infect Control Hosp Epidemiol. 2002;23:665–670. doi: 10.1086/501991. [DOI] [PubMed] [Google Scholar]
- 158.Birenbaum E, Linder N, Varsano N. Adenovirus type 8 conjunctivitis outbreak in a neonatal intensive care unit. Arch Dis Child. 1993;68:610–611. doi: 10.1136/adc.68.5_spec_no.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Sizun J, Soupre D, Legrand MC. Neonatal nosocomial respiratory infection with coronavirus: a prospective study in a neonatal intensive care unit. Acta Paediatr. 1995;84:617–620. doi: 10.1111/j.1651-2227.1995.tb13710.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Cunney RJ, Bialachowski A, Thornley D. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2000;21:449–554. doi: 10.1086/501786. [DOI] [PubMed] [Google Scholar]
- 161.Moisiuk SE, Robson D, Klass L. Outbreak of parainfluenza virus type 3 in an intermediate care neonatal nursery. Pediatr Infect Dis J. 1998;17:49–53. doi: 10.1097/00006454-199801000-00011. [DOI] [PubMed] [Google Scholar]
- 162.Sagrera X, Ginovart G, Raspall F. Outbreaks of influenza A virus infection in neonatal intensive care units. Pediatr Infect Dis J. 2002;21:196–200. doi: 10.1097/00006454-200203000-00007. [DOI] [PubMed] [Google Scholar]
- 163.Syriopoulou VP, Hadjichristodoulou C, Daikos GL. Clinical and epidemiological aspects of an enterovirus outbreak in a neonatal unit. J Hosp Infect. 2002;51:275–280. doi: 10.1053/jhin.2002.1253. [DOI] [PubMed] [Google Scholar]
- 164.Jankovic B, Pasic S, Kanjuh B. Severe neonatal echovirus 17 infection during a nursery outbreak. Pediatr Infect Dis J. 1999;18:393–394. doi: 10.1097/00006454-199904000-00023. [DOI] [PubMed] [Google Scholar]
- 165.Chambon M, Bailly JL, Beguet A. An outbreak due to echovirus type 30 in a neonatal unit in France in 1997: usefulness of PCR diagnosis. J Hosp Infect. 1999;43:63–68. doi: 10.1053/jhin.1999.0634. [DOI] [PubMed] [Google Scholar]
- 166.Griffin MP, O’Shea M, Brazy JE. Cytomegalovirus infection in a neonatal intensive care unit. Subsequent morbidity and mortality of seropositive infants. J Perinatol. 1990;10:43–45. [PubMed] [Google Scholar]
- 167.Vochem M, Hamprecht K, Jahn G, Speer CP. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J. 1998;17:53–58. doi: 10.1097/00006454-199801000-00012. [DOI] [PubMed] [Google Scholar]
- 168.Sawyer MH, Edwards DK, Spector SA. Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am J Dis Child. 1987;141:303–305. doi: 10.1001/archpedi.1987.04460030081030. [DOI] [PubMed] [Google Scholar]
- 169.Maschmann J, Hamprecht K, Dietz K. Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis. 2001;33:1998–2003. doi: 10.1086/324345. [DOI] [PubMed] [Google Scholar]
- 170.Hamprecht K, Maschmann J, Vochem M. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 2001;357:513–518. doi: 10.1016/S0140-6736(00)04043-5. [DOI] [PubMed] [Google Scholar]
- 171.Aitken C, Booth J, Booth M. Molecular epidemiology and significance of a cluster of cases of CMV infection occurring on a special care baby unit. J Hosp Infect. 1996;34:183–189. doi: 10.1016/s0195-6701(96)90064-x. [DOI] [PubMed] [Google Scholar]
- 172.Spector SA. Transmission of cytomegalovirus among infants in hospital documented by restriction-endonuclease-digestion analyses. Lancet. 1983;1:378–381. doi: 10.1016/s0140-6736(83)91499-x. [DOI] [PubMed] [Google Scholar]
- 173.Demmler GJ, Yow MD, Spector SA. Nosocomial cytomegalovirus infections within two hospitals caring for infants and children. J Infect Dis. 1987;156:9–16. doi: 10.1093/infdis/156.1.9. [DOI] [PubMed] [Google Scholar]
- 174.Sharland M, Khare M, Bedford-Russell A. Prevention of postnatal cytomegalovirus infection in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002;86:F140. doi: 10.1136/fn.86.2.F140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Linnemann CC, Jr, Buchman TG, Light IJ, Ballard JL. Transmission of herpes-simplex virus type 1 in a nursery for the newborn. Identification of viral isolates by DNA “fingerprinting.” Lancet. 1978;1:964–966. doi: 10.1016/s0140-6736(78)90251-9. [DOI] [PubMed] [Google Scholar]
- 176.Hammerberg O, Watts J, Chernesky M. An outbreak of herpes simplex virus type 1 in an intensive care nursery. Pediatr Infect Dis. 1983;2:290–294. doi: 10.1097/00006454-198307000-00007. [DOI] [PubMed] [Google Scholar]
- 177.Sakaoka H, Saheki Y, Uzuki K. Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns. J Clin Microbiol. 1986;24:36–40. doi: 10.1128/jcm.24.1.36-40.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Turner R, Shehab Z, Osborne K, Hendley JO. Shedding and survival of herpes simplex virus from ‘fever blisters.’. Pediatrics. 1682;70:547–549. [PubMed] [Google Scholar]
- 179.Hayakawa M, Kimura H, Ohshiro M. Varicella exposure in a neonatal medical centre: successful prophylaxis with oral acyclovir. J Hosp Infect. 2003;54:212–215. doi: 10.1016/s0195-6701(03)00144-0. [DOI] [PubMed] [Google Scholar]
- 180.Stover BH, Cost KM, Hamm C. Varicella exposure in a neonatal intensive care unit: case report and control measures. Am J Infect Control. 1988;16:167–172. doi: 10.1016/0196-6553(88)90028-4. [DOI] [PubMed] [Google Scholar]
- 181.Klein BS, Michaels JA, Rytel MW. Nosocomial hepatitis A. A multinursery outbreak in Wisconsin. JAMA. 1984;252:2716–2721. doi: 10.1001/jama.252.19.2716. [DOI] [PubMed] [Google Scholar]
- 182.Watson JC, Fleming DW, Borella AJ. Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. J Infect Dis. 1993;167:567–5571. doi: 10.1093/infdis/167.3.567. [DOI] [PubMed] [Google Scholar]
- 183.Rosenblum LS, Villarino ME, Nainan OV. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis. 1991;164:476–482. doi: 10.1093/infdis/164.3.476. [DOI] [PubMed] [Google Scholar]
- 184.Haley RW, Culver DH, White JW. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121:182–205. doi: 10.1093/oxfordjournals.aje.a113990. [DOI] [PubMed] [Google Scholar]
- 185.Adams-Chapman I, Stoll BJ. Prevention of nosocomial infections in the neonatal intensive care unit. Curr Opin Pediatr. 2002;14:157–164. doi: 10.1097/00008480-200204000-00003. [DOI] [PubMed] [Google Scholar]
- 186.Lee TB, Baker OG, Lee JT. Recommended practices for surveillance. Association for Professionals in Infection Control and Epidemiology, Inc. Surveillance Initiative working group. Am J Infect Control. 1998;26:277–288. doi: 10.1016/s0196-6553(98)80013-8. [DOI] [PubMed] [Google Scholar]
- 187.Lee T, Baker-Montgomery O. Surveillance. In: Carrico R, editor. APIC Text for Infection Control and Epidemiology. Association for Professionals in Infection Control and Epidemiology; Washington, DC: 2002. pp 13–1–13–15. [Google Scholar]
- 188.Gaynes R, Horan T. Surveillance of nosocomial infections. In: Mayhall C, editor. Hospital Epidemiology and Infection Control. Lippincott Williams & Wilkins; Philadelphia: 1999. pp. 1285–1317. [Google Scholar]
- 189.Joint Commission on Accreditation of Healthcare Organizations . Surveillance, Prevention and Control of Infection, 2005 Pre-Publication Edition. Joint Commission on Accreditation of Healthcare Organizations; Oak Brook Terrace, Ill: 2003. pp. 1–11.Available at http://www.jcaho.org/accredited+organizations/patient+safety/infection+control/05_ic_std_hap.pdf [Google Scholar]
- 190.Emori TG, Culver DH, Horan TC. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control. 1991;19:19–35. doi: 10.1016/0196-6553(91)90157-8. [DOI] [PubMed] [Google Scholar]
- 191.Garner JS, Jarvis WR, Emori TG. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–140. doi: 10.1016/0196-6553(88)90053-3. [DOI] [PubMed] [Google Scholar]
- 192.Moore D. Nosocomial infections in newborn nurseries and neonatal intensive care units. In: Mayhall C, editor. Hospital Epidemiology and Infection Control. Lippincott Williams & Wilkins; Philadelphia: 1999. pp. 665–693. [Google Scholar]
- 193.Sinha A, Yokow D, Platt R. Epidemiology of neonatal infections: experience during and after hospitalization. Pediatr Infect Dis J. 2003;22:244–250. doi: 10.1097/01.inf.0000055060.32226.8a. [DOI] [PubMed] [Google Scholar]
- 194.Centers for Disease Control and Prevention, Division of Health Care Quality Promotion National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control. 2003;30:481–498. doi: 10.1016/j.ajic.2003.09.002. [DOI] [PubMed] [Google Scholar]
- 195.Siegel JD. The Newborn Nursery. In: Bennet J, Brachman P, editors. Hospital Infections. 4th ed. Lippincott-Raven; Philadelphia: 1998. pp. 403–420. [Google Scholar]
- 196.Gaynes RP, Solomon S. Improving hospital-acquired infection rates: the CDC experience. J Comm J Qual Improv. 1996;22:457–467. doi: 10.1016/s1070-3241(16)30248-6. [DOI] [PubMed] [Google Scholar]
- 197.Archibald LK, Gaynes RP. Hospital-acquired infections in the United States. The importance of interhospital comparisons. Infect Dis Clin North Am. 1997;11:245–255. doi: 10.1016/s0891-5520(05)70354-8. [DOI] [PubMed] [Google Scholar]
- 198.Stover BH, Shulman ST, Bratcher DF. Nosocomial infection rates in US children’s hospitals’ neonatal and pediatric intensive care units. Am J Infect Control. 2001;29:152–157. doi: 10.1067/mic.2001.115407. [DOI] [PubMed] [Google Scholar]
- 199.Checko PJ. Outbreak investigation. In: Carrico R, editor. APIC Text for Infection Control and Epidemiology. Association for Professionals in Infection Control and Epidemiology; Washington, DC: 2002. 15–1–15–9. [Google Scholar]
- 200.Haas JP, Trezza LA. Outbreak investigation in a neonatal intensive care unit. Semin Perinatol. 2002;26:367–378. doi: 10.1053/sper.2002.36270. [DOI] [PubMed] [Google Scholar]
- 201.van Acker J, de Smet F, Muyldermans G. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol. 2001;39:293–297. doi: 10.1128/JCM.39.1.293-297.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 202.McDonald LC, Walker M, Carson L. Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J. 1998;17:716–722. doi: 10.1097/00006454-199808000-00011. [DOI] [PubMed] [Google Scholar]
- 203.Zafar AB, Sylvester LK, Beidas SO. Pseudomonas aeruginosa infections in a neonatal intensive care unit. Am J Infect Control. 2002;30:425–429. doi: 10.1067/mic.2002.121153. [DOI] [PubMed] [Google Scholar]
- 204.Steppberger K, Walter S, Claros MC. Nosocomial neonatal outbreak of Serratia marcescens—analysis of pathogens by pulsed field gel electrophoresis and polymerase chain reaction. Infection. 2002;30:277–281. doi: 10.1007/s15010-002-2141-y. [DOI] [PubMed] [Google Scholar]
- 205.Chaberny IE, Schnitzler P, Geiss HK, Wendt C. An outbreak of epidemic keratoconjunctivitis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol. 2003;24:514–519. doi: 10.1086/502247. [DOI] [PubMed] [Google Scholar]
- 206.Wilcox MH, Fitzgerald P, Freeman J. A five year outbreak of methicillin-susceptible Staphylococcus aureus phage type 53,85 in a regional neonatal unit. Epidemiol Infect. 2000;124:37–45. doi: 10.1017/s0950268899003349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 207.Nambiar S, Herwaldt LA, Singh N. Outbreak of invasive disease caused by methicillin-resistant Staphylococcus aureus in neonates and prevalence in the neonatal intensive care unit. Pediatr Crit Care Med. 2003;4:220–226. doi: 10.1097/01.PCC.0000059736.20597.75. [DOI] [PubMed] [Google Scholar]
- 208.Kilani RA. Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases. J Trop Pediatr. 2002;48:118–122. doi: 10.1093/tropej/48.2.118. [DOI] [PubMed] [Google Scholar]
- 209.Pessoa-Silva CL, Toscano CM, Moreira BM. Infection due to extended-spectrum beta-lactamase-producing Salmonella enterica subsp. enterica serotype infantis in a neonatal unit. J Pediatr. 2002;141:381–387. doi: 10.1067/mpd.2002.127279. [DOI] [PubMed] [Google Scholar]
- 210.Alfa MJ, Robson D, Davi M. An outbreak of necrotizing enterocolitis associated with a novel clostridium species in a neonatal intensive care unit. Clin Infect Dis. 2002;35:S101–S105. doi: 10.1086/341929. [DOI] [PubMed] [Google Scholar]
- 211.Hoque SN, Graham J, Kaufmann ME, Tabaqchali S. Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect. 2001;47:188–192. doi: 10.1053/jhin.2000.0908. [DOI] [PubMed] [Google Scholar]
- 212.Lo WT, Wang CC, Chu ML. A nursery outbreak of Staphylococcus aureus pyoderma originating from a nurse with paronychia. Infect Control Hosp Epidemiol. 2002;23:153–155. doi: 10.1086/502028. [DOI] [PubMed] [Google Scholar]
- 213.Ng W, Rajadurai VS, Pradeepkumar VK. Parainfluenza type 3 viral outbreak in a neonatal nursery. Ann Acad Med Singapore. 1999;28:471–475. [PubMed] [Google Scholar]
- 214.Larson EL, Early E, Cloonan P. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med. 2000;26:14–22. doi: 10.1080/08964280009595749. [DOI] [PubMed] [Google Scholar]
- 215.Pittet D. Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis. 2001;7:234–240. doi: 10.3201/eid0702.010217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 216.American Academy of Pediatrics and American College of Obstetricians and Gynecologists . Inpatient perinatal care services. In: Gilstrap LC, Oh W, editors. Guidelines for Perinatal Care. 5th ed. American Academy of Pediatrics, and Washington, DC, American College of Obstetricians and Gynecologists; Elk Grove Village, Ill: 2002. pp. 17–55. [Google Scholar]
- 217.Salisbury DM, Hutfilz P, Treen LM. The effect of rings on microbial load of health care workers’ hands. Am J Infect Control. 1997;25:24–27. doi: 10.1016/s0196-6553(97)90049-3. [DOI] [PubMed] [Google Scholar]
- 218.Trick WE, Vernon MO, Hayes RA. Impact of ring wearing on hand contamination and comparison of hand hygiene agents in a hospital. Clin Infect Dis. 2003;36:1383–1390. doi: 10.1086/374852. [DOI] [PubMed] [Google Scholar]
- 219.Pelke S, Ching D, Easa D, Melish ME. Gowning does not affect colonization or infection rates in a neonatal intensive care unit. Arch Pediatr Adolesc Med. 1994;148:1016–1020. doi: 10.1001/archpedi.1994.02170100014004. [DOI] [PubMed] [Google Scholar]
- 220.Birenbaum HJ, Glorioso L, Rosenberger C. Gowning on a postpartum ward fails to decrease colonization in the newborn infant. Am J Dis Child. 1990;144:1031–1033. doi: 10.1001/archpedi.1990.02150330091029. [DOI] [PubMed] [Google Scholar]
- 221.American Academy of Pediatrics and American College of Obstetricians and Gynecologists . Infection control. In: Gilstrap LC, Oh W, editors. Guidelines for Perinatal Care. 5th ed. American Academy of Pediatrics, and Washington, DC, American College of Obstetricians and Gynecologists; Elk Grove Village, Ill: 2002. pp. 331–353. [Google Scholar]
- 222.American Academy of Pediatrics . Infection control for hospitalized children. In: Pickering LK, editor. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. American Academy of Pediatrics; Elk Grove Village, Ill: 2003. pp. 146–155. [Google Scholar]
- 223.Bozzi D, Burwen D, Dooley S. Guideline for preventing the transmission of Mycobacterium tuberculosis in health care facilities. MMWR Mortal Morb Wkly Rep. 1994;43:1–132. [PubMed] [Google Scholar]
- 224.Munoz FM, Ong LT, Seavy D. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children’s hospital. Infect Control Hosp Epidemiol. 2002;23:568–572. doi: 10.1086/501972. [DOI] [PubMed] [Google Scholar]
- 225.Bowie BH, Hall RB, Faulkner J, Anderson B. Single-room infant care: future trends in special care nursery planning and design. Neonatal Netw. 2003;22:27–34. doi: 10.1891/0730-0832.22.4.27. [DOI] [PubMed] [Google Scholar]
- 226.Harrison H. The principles for family-centered neonatal care. Pediatrics. 1993;92:643–650. [PubMed] [Google Scholar]
- 227.White RD, Brown J, Cicco R. Recommended standards for newborn ICU design: report of the Fifth Consensus Conference on newborn ICU design. Consensus Committee to Establish Recommended Standards for Newborn ICU Design; Clearwater Beach, Fla: 2002. Available at http://www.nd.edu/∼kkolberg/DesignStandards.htm [Google Scholar]
- 228.Brown DG, Baublis J. Reservoirs of Pseudomonas in an intensive care unit for newborn infants: mechanisms of control. J Pediatr. 1977;90:453–457. doi: 10.1016/s0022-3476(77)80715-4. [DOI] [PubMed] [Google Scholar]
- 229.Bert F, Maubec E, Bruneau B. Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit. J Hosp Infect. 1998;39:53–62. doi: 10.1016/s0195-6701(98)90243-2. [DOI] [PubMed] [Google Scholar]
- 230.Kappstein I, Grundmann H, Hauer T, Niemeyer C. Aerators as a reservoir of Acinetobacter junii: an outbreak of bacteraemia in paediatric oncology patients. J Hosp Infect. 2000;44:27–30. doi: 10.1053/jhin.1999.0648. [DOI] [PubMed] [Google Scholar]
- 231.Sehulster L, Chinn RY. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Health Care Infection Control Practices Advisory Committee (HICPAC) MMWR Recomm Rep. 2003;52:1–42. [PubMed] [Google Scholar]
- 232.Moore D. Newborn nursery and neonatal intensive care unit. In: Carrico R, editor. APIC Text of Infection Control and Epidemiology. Association for Professionals in Infection Control and Epidemiology; Washington, DC: 2002. pp. 48–55. [Google Scholar]
- 233.Rutala WA. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control. 1996;24:313–342. doi: 10.1016/s0196-6553(96)90066-8. [DOI] [PubMed] [Google Scholar]
- 234.Pugliese G, Hubbard C. Central services, linens, and laundry. In: Bennett JV, Brachman P, editors. Hospital Infections. 4th ed. Lippincott-Raven; Philadelphia: 1998. pp. 725–739. [Google Scholar]
- 235.Rhame FS. The inanimate environment. In: Bennett JV, Brachman P, editors. Hospital Infections. 4th ed. Lippincott-Raven; Philadelphia: 1998. pp. 299–324. [Google Scholar]
- 236.Centers for Disease Control and Prevention, Health Care Infections Control Practices Advisory Committee (HICPAC) Guidelines for environmental infection control in health-care facilities. American Society for Health Care Engineering and the American Hospital Association; Chicago, Ill: 2004. [Google Scholar]
- 237.Hall CB, Douglas RG, Jr, Geiman JM, Messner MK. Nosocomial respiratory syncytial virus infections. N Engl J Med. 1975;293:1343–1346. doi: 10.1056/NEJM197512252932604. [DOI] [PubMed] [Google Scholar]
- 238.Hall CB, Kopelman AE, Douglas RG., Jr Neonatal respiratory syncytial virus infection. N Engl J Med. 1979;300:393–396. doi: 10.1056/NEJM197902223000803. [DOI] [PubMed] [Google Scholar]
- 239.Hall CB, Geiman JM, Douglas RG, Jr, Meagher MP. Control of nosocomial respiratory syncytial viral infections. Pediatrics. 1978;62:728–732. [PubMed] [Google Scholar]
- 240.American Academy of Pediatrics . Herpes simplex. In: Pickering LK, editor. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. American Academy of Pediatrics; Elk Grove Village, Ill: 2003. pp. 344–353. [Google Scholar]
- 241.American Academy of Pediatrics . Cytomegalovirus infection. In: Pickering LK, editor. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. American Academy of Pediatrics; Elk Grove Village, Ill: 2003. pp. 259–262. [Google Scholar]
- 242.Ahlfors K, Ivarsson SA, Johnsson T, Renmarker K. Risk of cytomegalovirus infection in nurses and congenital infection in their offspring. Acta Paediatr Scand. 1981;70:819–823. doi: 10.1111/j.1651-2227.1981.tb06233.x. [DOI] [PubMed] [Google Scholar]
- 243.Balcarek KB, Bagley R, Cloud GA, Pass RF. Cytomegalovirus infection among employees of a children’s hospital. No evidence for increased risk associated with patient care. JAMA. 1990;263:840–844. [PubMed] [Google Scholar]
- 244.Fridkin SK, Pear SM, Williamson TH. The role of understaffing in central venous catheter–associated bloodstream infections. Infect Control Hosp Epidemiol. 1996;17:150–158. doi: 10.1086/647262. [DOI] [PubMed] [Google Scholar]
- 245.American Academy of Pediatrics and American College of Obstetricians and Gynecologists . Perinatal infections. In: Gilstrap LC, Oh W, editors. Guidelines for Perinatal Care. 5th ed. American Academy of Pediatrics, and Washington, DC, American College of Obstetricians and Gynecologists; Elk Grove Village, Ill: 2002. pp. 285–329. [Google Scholar]
- 246.Brunell PA. Fetal and neonatal varicella-zoster infections. Semin Perinatol. 1983;7:47–56. [PubMed] [Google Scholar]
- 247.Fallot ME, Boyd JL, 3rd, Oski FA. Breast-feeding reduces incidence of hospital admissions for infection in infants. Pediatrics. 1980;65:1121–1124. [PubMed] [Google Scholar]
- 248.American Academy of Pediatrics . Human milk. In: Pickering LK, editor. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. American Academy of Pediatrics; Elk Grove Village, Ill: 2003. pp. 117–123. [Google Scholar]
- 249.American Academy of Pediatrics and American College of Obstetricians and Gynecologists . Care of the neonate. In: Gilstrap LC, Oh W, editors. Guidelines for Perinatal Care. 5th ed. American Academy of Pediatrics, and Washington, DC, American College of Obstetricians and Gynecologists; Elk Grove Village, Ill: 2002. pp. 187–235. [Google Scholar]
- 250.el-Mohandes AE, Schatz V, Keiser JF, Jackson BJ. Bacterial contaminants of collected and frozen human milk used in an intensive care nursery. Am J Infect Control. 1993;21:226–230. doi: 10.1016/0196-6553(93)90413-x. [DOI] [PubMed] [Google Scholar]
- 251.D’Amico CJ, DiNardo CA, Krystofiak S. Preventing contamination of breast pump kit attachments in the NICU. J Perinat Neonatal Nurs. 2003;17:150–157. doi: 10.1097/00005237-200304000-00007. [DOI] [PubMed] [Google Scholar]
- 252.Baker RD. Infant formula safety. Pediatrics. 2002;110:833–835. doi: 10.1542/peds.110.4.833. [DOI] [PubMed] [Google Scholar]
- 253.Nyqvist KH, Lutes LM. Co-bedding twins: a developmentally supportive care strategy. J Obstet Gynecol Neonatal Nurs. 1998;27:450–456. doi: 10.1111/j.1552-6909.1998.tb02669.x. [DOI] [PubMed] [Google Scholar]
- 254.DellaPorta K, Aforismo D, Butler-O’Hara M. Co-bedding of twins in the neonatal intensive care unit. Pediatr Nurs. 1998;24:529–531. [PubMed] [Google Scholar]
- 255.Wittrock B, Lavin MA, Pierry D. Parents as a vector for nosocomial infection in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2001;22:472. doi: 10.1086/503404. [DOI] [PubMed] [Google Scholar]
- 256.Cartolano GL, Moulies ME, Seguier JC, Boisivon A. A parent as a vector of Salmonella brandenburg nosocomial infection in a neonatal intensive care unit. Clin Microbiol Infect. 2003;9:560–562. doi: 10.1046/j.1469-0691.2003.00562.x. [DOI] [PubMed] [Google Scholar]
- 257.Darmstadt GL, Dinulos JG. Neonatal skin care. Pediatr Clin North Am. 2000;47:757–782. doi: 10.1016/s0031-3955(05)70239-x. [DOI] [PubMed] [Google Scholar]
- 258.Mullany LC, Darmstadt GL, Tielsch JM. Role of antimicrobial applications to the umbilical cord in neonates to prevent bacterial colonization and infection: review of the evidence. Pediatr Infect Dis J. 2003;22:996–1002. doi: 10.1097/01.inf.0000095429.97172.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 259.Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med. 1995;332:562–566. doi: 10.1056/NEJM199503023320903. [DOI] [PubMed] [Google Scholar]
- 260.Isenberg SJ, Apt L, Campeas D. Ocular applications of povidone-iodine. Dermatology. 2002;204(Suppl 1):92–95. doi: 10.1159/000057733. [DOI] [PubMed] [Google Scholar]
- 261.Smith J, Finn A. Antimicrobial prophylaxis. Arch Dis Child. 1999;80:388–392. doi: 10.1136/adc.80.4.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 262.Garland JS, Dunne WM, Jr, Havens P. Peripheral intravenous catheter complications in critically ill children: A prospective study. Pediatrics. 1992;89:1145–1150. [PubMed] [Google Scholar]
- 263.Centers for Disease Control and Prevention Guidelines for prevention of nosocomial pneumonia. MMWR Morb Mortal Wkly Rep. 1997;46(No. RR-1):1–79. [PubMed] [Google Scholar]
- 264.Kawagoe JY, Segre CA, Pereira CR. Risk factors for nosocomial infections in critically ill newborns: a 5-year prospective cohort study. Am J Infect Control. 2001;29:109–114. doi: 10.1067/mic.2001.114162. [DOI] [PubMed] [Google Scholar]
- 265.Pepe R. Nosocomial pneumonia. In: Carrico R, editor. APIC Text of Infection Control and Epidemiology. Association for Professionals in Infection Control and Epidemiology; Washington, DC: 2002. pp 88–1–88–3. [Google Scholar]
- 266.Craven DE, Steger KA. Hospital-acquired pneumonia: perspectives for the health care epidemiologist. Infect Control Hosp Epidemiol. 1997;18:783–795. doi: 10.1086/647540. [DOI] [PubMed] [Google Scholar]
- 267.Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med. 1999;340:627–634. doi: 10.1056/NEJM199902253400807. [DOI] [PubMed] [Google Scholar]
- 268.Lesiuk W, Lesiuk L, Maliczowska M, Puzniak G. Non-invasive mandatory ventilation in extremely low birth weight and very low birth weight newborns with failed respiration. Przegl Lek. 2002;59(Suppl 1):57–59. [PubMed] [Google Scholar]
- 269.Fernandez-Jurado MI, Fernandez-Baena M. Use of laryngeal mask airway for prolonged ventilatory support in a preterm newborn. Paediatr Anaesth. 2002;12:369–370. doi: 10.1046/j.1460-9592.2002.00854.x. [DOI] [PubMed] [Google Scholar]
- 270.Lien TC, Lin MY, Chu CC. Ventilator-associated pneumonia with circuit changes every 2 days versus every week. Zhonghua Yi Xue Za Zhi (Taipei) 2001;64:161–167. [PubMed] [Google Scholar]
- 271.Kotilainen HR, Keroack MA. Cost analysis and clinical impact of weekly ventilator circuit changes in patients in intensive care unit. Am J Infect Control. 1997;25:117–120. doi: 10.1016/s0196-6553(97)90038-9. [DOI] [PubMed] [Google Scholar]
- 272.Stoller JK, Orens DK, Fatica C. Weekly versus daily changes of in-line suction catheters: impact on rates of ventilator-associated pneumonia and associated costs. Respir Care. 2003;48:494–499. [PubMed] [Google Scholar]
- 273.Zeitoun SS, de Barros AL, Diccini S. A prospective, randomized study of ventilator-associated pneumonia in patients using a closed vs. open suction system. J Clin Nurs. 2003;12:484–489. doi: 10.1046/j.1365-2702.2003.00749.x. [DOI] [PubMed] [Google Scholar]
- 274.Deppe SA, Kelly JW, Thoi LL. Incidence of colonization, nosocomial pneumonia, and mortality in critically ill patients using a Trach Care closed-suction system versus an open-suction system: prospective, randomized study. Crit Care Med. 1990;18:1389–1393. doi: 10.1097/00003246-199012000-00016. [DOI] [PubMed] [Google Scholar]
- 275.Bergmans DC, Bonten MJ, Gaillard CA. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2001;164:382–388. doi: 10.1164/ajrccm.164.3.2005003. [DOI] [PubMed] [Google Scholar]
- 276.Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA. 1991;265:2704–2710. [PubMed] [Google Scholar]
- 277.Cook DJ, Reeve BK, Guyatt GH. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996;275:308–314. [PubMed] [Google Scholar]
- 278.Ildizdas K, Yapicioglu H, Yilmaz H. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J Crit Care. 2002;17:240–245. doi: 10.1053/jcrc.2002.36761. [DOI] [PubMed] [Google Scholar]
- 279.Lopriore E, Markhorst DG, Gemke RJ. Ventilator-associated pneumonia and upper airway colonisation with gram negative bacilli: the role of stress ulcer prophylaxis in children. Intensive Care Med. 2002;28:763–767. doi: 10.1007/s00134-002-1289-3. [DOI] [PubMed] [Google Scholar]
